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La Crosse virus (LACV) was first recognized as a cause of pediatric viral 
encephalitis in the upper-Midwestern United States following its isolation from a fatal 
case of pediatric encephalitis in 1964.  From that time, LACV infections have been 
reported in 24 states, with the number of reported cases increasing in recent years in the 
Appalachian region of the United States.  Two states in Appalachia, West Virginia and 
Tennessee have both seen a large rise in the number of reported cases in recent years. 
To investigate the epidemiology of the LACV infections in the eastern United 
States, Tennessee, and West Virginia a combination of field and laboratory studies were 
initiated.  These studies investigated the spatial and temporal patterns of disease risk and 
the biology and ecosystem dynamics of both indigenous and invasive disease vectors. 
Four distinct regional clusters of LACV infections were detected at the national 
level, as well as a higher incidence risk and case-fatality rate than previously reported.  
The exploration into the variations of risk using different at-risk populations and 
geographic scales revealed the possibility of missing disease clusters resulting from 
performing incidence risk investigations of focal diseases using inappropriate at-risk 
populations and/or large geographic scales.  South-central West Virginia was found to be 
a focus of LACV transmission and in addition to having the highest incidence risk and 
case-fatality rate reported in the United States.   
In eastern Tennessee, Aedes albopictus was found to be the most abundant 
mosquito collected at all sites and vegetation types, by both CO2-baited CDC trapping 
and human landing catches.  Results from the use of variable pressure scanning electron 
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microscopy to describe the egg of Aedes japonicus have provided more detailed 
information on characters of Aedini eggs, while bringing the number of more complete 
descriptions and micrographs of the micropyle and associated structures of the subgenus 
Finlaya to three. 
The results of these studies have provided a more complete understanding of the 
epidemiology of LACV and its associated vector species at both the national and state 
levels.  These findings will help guide future research and intervention efforts to 
understand and prevent virus transmission.  
 
 vii 
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La Crosse virus (LACV) was first isolated from the brain of a deceased pediatric 
patient who died of encephalitis in 1964 [1], and is one of the most common causes of 
pediatric arboviral encephalitis in the United States [2,3].  The traditional focus of virus 
transmission has been in the upper-Midwestern United States [2,4,5], but more recently 
LACV has been seen as an emerging disease in Tennessee and West Virginia [6,7,8,9].  
Following the initial outbreaks of infections in 1987 and 1997, LACV infections have 
continued to rise in both Tennessee and West Virginia respectively [6,10].  This project 
set out to (1) determine the current spatial and temporal patterns of disease risk for 
LACV first at the national level, and then within Tennessee and West Virginia, and (2) to 
determine the current vector ecosystem dynamics in eastern Tennessee.  
Prior to this project the spatial epidemiology of LACV at the national and state 
levels were not well understood, and only one study of the spatial clustering and risk 
factors of LACV had been reported in the literature [11], though foci were known to exist 
in several states [4,5,12,13,14].  Additionally, reported incidence risks for LACV were 
limited [10,15].  Therefore, this project conducted spatial and temporal analyses of 
LACV infections and to determine those areas of highest risk both nationally and at the 
census tract level for Tennessee and West Virginia. 
The effect that the indigenous vector Aedes triseriatus and two invasive mosquito 
vectors, Aedes albopictus and Ae. japonicus, have on the sylvatic and urban transmission 
cycles of LACV in eastern Tennessee is unknown, though previous studies in Tennessee 
and West Virginia both have shown that both invasive species could be playing roles as 
accessory LACV vectors [16,17,18,19].  The role of Ae. triseriatus in LACV 
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transmission is well understood [20,21,22], and though Ae. albopictus and Ae. japonicus 
have been shown to be competent laboratory vectors [17,23,24], the role of 
environmental and habitat characteristics affecting these species vectorial status in 
eastern Tennessee remained in question.  To further the understanding of the ecology of 
vector species and the ecosystem dynamics surrounding LACV transmission, field 
studies were undertaken in eastern Tennessee from 2004 to 2006.  To provide more 
detailed information on characters of Aedini eggs, and in an effort to assist field 
biologists in the identification of predominantly collected tree-hole species/container 
species, the egg of Ae. japonicus was described with the aid of the variable pressure 
scanning electron microscope. 
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La Crosse virus (LACV) is a member of the genus Orthobunyavirus, family 
Bunyaviridae, and is the causative agent of LACV infections.  LACV was first isolated in 
1964 [1], and since that time has become one of most common causes of pediatric 
arboviral infections in the United States [2,3].  LACV has traditionally been associated 
with forested areas in the upper-midwestern United States [4], but more recently as an 
emerging disease in the Appalachian region of the United States [6,8,9].  The majority of 
LACV infections are transmitted to humans through the bite of the primary vector, the 
eastern tree-hole mosquito, Aedes triseriatus [20,25].  The virus is maintained in nature 
through a vertical and horizontal transmission cycle involving Ae. triseriatus [21,22,26] 
and the primary amplification hosts: the eastern chipmunk, Tamias striatus, the gray 
squirrel, Sciurus carolinensis, and the fox squirrel Sciurus niger [27,28]. 
Since its recognition as a cause of human illness, LACV infections have been 
reported in 24 states [29], with the number of reported cases increasing in recent years in 
the Appalachian region of the United States [6,8,9,10].  Two states in Appalachia, West 
Virginia and Tennessee have both seen a large rise in the number of reported cases in 
recent years following initial large outbreaks of infections in 1987 and in 1997, 
respectively [6,10].  Following these outbreaks the virus became a seasonally recognized 
cause of viral encephalitis in these States [6,16,30].   
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Risk Factors  
Following the initial outbreak in West Virginia, a case control study was 
undertaken to determine the effects tree holes, artificial containers, and environmental 
and behavioral characteristics have upon the transmission of LACV in West Virginia 
[30].  A slight increase in risk (OR < 2.0) was found for an increased time spent outdoors, 
the non-use of insect repellant, the non-use of air conditioning, a lack of screened 
windows, and the non-use of protective clothing.  The presence of tree holes near a 
residence was found to significantly increase the risk of transmission (OR = 8.5 for  1 
tree hole vs. 0 tree holes).  
Factors that were found to not statistically significantly increase the risk of 
disease transmission were artificial containers (OR = 4.1 for  6 containers vs. 0 to 5 
containers), discarded tires (OR = 3.2 for  10 tires vs. 0 to 9 tires), and the proximity to 
forest edge (OR = 3.2 for 0 to 14.9 m vs.  14.9 m).  The authors concluded that though 
these factors were not statistically significant, they could still result in increased disease 
transmission not detected due to limitations of the study.  This study took place during a 
period of low rainfall, and authors hypothesized that tree holes would hold larger 
amounts of water than artificial containers.  Therefore, tree holes would provide more 
larval habitat than artificial containers during these periods of time, biasing the results. 
The matching of controls by social and economic characters may have limited the study‟s 
ability to detect differences between study households, i.e., the number of tires in 
proximity to households. 
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Further limitations of this study identified by the authors included the lack of 
larvae collected and identified near residences due to the time of year (autumn), the 
inclusion of a study area around the residence of 91.4 m, though children would have 
spent a larger proportion of time beyond this radius.  The authors concluded that these 
results could have under or over-estimated disease transmission in the periodomestic 
environment. 
In 2002, the first blinded case control study looking at the clinical, environmental, 
and the entomological characteristics of LACV was carried out in eastern Tennessee [16].  
Significant factors found to be associated with LACV infection were found to be the 
number of hours per day spent outdoors (5.9 for LACE cases vs. 4.0 for non-cases, p = 
0.05) and living in a residence with one or more tree holes within a 100 m radius from the 
dwelling (relative risk of 3.96 vs. no tree holes in a 100bm radius, p = 0.05). No 
correlation was made with the type of clothing worn, the use of insect repellant, or the 
use of screens on open windows. 
Vector Surveillance 
In Nicholas County, West Virginia, Nasci et al. [9] conducted a study to associate 
habitat with the transmission of LACV in 1996, prior to the establishment of Ae. 
albopictus in West Virginia.  Sites were characterized by habitat type, distance from 
reported case sites of LACV infections, and included both host-seeking and ovitrapping 
mosquito collections.  LACV-infected Ae. triseriatus species were found at all study 
sites.  Aedes triseriatus eggs were used a measure of population density and showed an 
increase in population from the beginning of the season through mid-July, from mid-July 
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through early-September populations plateaued, with population densities greatest (38 
percent to 46 percent) at collection sites adjacent to reported cases of LACV infections.  
The seasonal total LACV infection rates in transovarially infected mosquitoes was found 
to range from 0.4/1,000 to 7.5/1,000 and were not found to be statistically significant by 
either habitat characterization or distance to reported LACV infection case sites.  The 
season total LACV minimum infection rates ranged from 4.3/1,000 to 27/1,000 in host-
seeking Ae. triseriatus species collected and from 1.6/1,000 to 2.4/1,000 for host-seeking 
Ae. canadensis an accessory vector of LACV [31,32].  There was no significant 
difference found between habitat type and distance to reported cases of LAC encephalitis 
and the presence of infected mosquitoes. 
Starting in 1992 and continuing through 2003, the results from a series of studies 
[18,19,33,34] inferred the distribution and seasonality of mosquito vectors in West 
Virginia.  The first of these studies found that populations of Ae. triseriatus were 
distributed throughout the state and at all elevations sampled [34].  Aedes triseriatus 
larvae were found to be significantly (p < 0.05) associated with shaded habitats.   
Following this study the presence of vector species was investigated at waste tire 
dumps in Nicholas County [18].  The authors found that Ae. triseriatus was the most 
abundant species collected, and it was significantly more likely (p < 0.05) to be collected 
in forested habitat, while Ae. albopictus larvae were significantly (p < 0.05) more likely 
to be collected in peridomestic areas.   
In 2002, Joy et al. [33] observed that Ae. triseriatus was the most abundant 
species collected from abandoned tire pile sites, except during September when Ae. 
albopictus and Aedes japonicus were found to be more abundant.  It appears that during 
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this time period between 2001 and 2002, Ae. albopictus and Ae. japonicus became firmly 
established in West Virginia and their respective populations increased.   
In a 2003, a follow-up study conducted to determine the occurrence of mosquito 
larvae inhabiting tires in different geographic regions (western, central, and eastern) of 
the state [19] provides the most recent account of the biology and distribution of vector 
species in West Virginia.  Aedes japonicus was found to be the most commonly collected 
species in the state in all geographical regions.  Populations of Ae. japonicus remained 
roughly constant throughout the season, except for lower collections made in March and 
April in the western region of the state.  Aedes japonicus was significantly more abundant 
(p < 0.05) than Ae. triseriatus in the eastern region of the state and in peridomestic areas 
in all regions, though both species were found to be collected at relative numbers in non-
peridomestic areas.   
Aedes triseriatus was the second most abundant species collected in West 
Virginia.  In agreement with previous work [34], populations peaked roughly in August 
and declined into October.  Aedes albopictus collected experienced low numbers from 
April through June, with numbers gradually increasing until October.  It was most 
frequently collected in the western region of the state, with the central region have fewer 
collections, and the eastern region having the lowest number of collections.  Populations 
were similar at both peridomestic and non-peridomestic sites.  Numbers of Ae. triseriatus 
were found to be significantly greater (p < 0.05) than collections of Ae. albopictus in both 
peridomestic and non-peridomestic sites in the central and eastern regions of the state.   
This study inferred a shift in vector abundance with Ae. japonicus being collected 
more frequently than Ae. triseriatus in all geographic regions of West Virginia, thus 
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increasing the likelihood that this species could be an accessory vector of LACV in West 
Virginia.  The findings that Ae. albopictus were collected at significantly lower (p < 0.05) 
numbers than Ae. triseriatus at both peridomestic and non-peridomestic sites in the 
central and eastern regions of the state could have implications for its role as an accessory 
vector of LACV in these regions [9,10,30], though virus isolation studies are needed to 
confirm this hypothesis. 
Similar studies were carried out in Tennessee following the initial LACV 
outbreak in 1997.  These studies took place following the establishment of Ae. albopictus.  
In order to assess the temporal patterns, parity, survival rates and vector potential in both 
Ae. albopictus and Ae. triseriatus surveillance was undertaken at two case sites of LACV 
infections that occurred in 1997 [35].  This study showed that the monthly mean parity 
rates for Ae. albopictus from July through October ranged from 0.78 to 0.92, and did not 
differ significantly (p > 0.05) between the two LACV infection sites.  The monthly mean 
parity rates for Ae. triseriatus adults ranged from 0.71 to 0.80 during the study period, but 
low numbers of collected Ae. triseriatus prevented statistical comparison with parous Ae. 
albopictus.  The estimated survival rate of adult Ae. albopictus females ranged from 0.92 
to 0.99 during this period.  The high parity and survival of Ae. albopictus adults indicated 
that a large percentage of the population was multi-parous, thus increasing the chances of 
becoming infected and transmitting LACV. 
The first isolate of LACV in Tennessee, came from Ae. albopictus (TN00-2266) 
resulting from follow-up vector surveillance at a LACV infection case site in 1999 [17].  
The minimum infection rate for Ae. albopictus eggs oviposited at the site was determined 
to be 6.5/1000 for the isolation week, with a ratio of collected Ae. albopictus to Ae. 
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triseriatus of 153:1.  This residence was well maintained within an oak and hickory forest 
located 15 meters from the residence.  A later study [16], found that the burden of Ae. 
albopictus collected (three times greater at cases than non-cases, p = 0.013) was a 
significant risk factor associated with LACV infection.  The results of this study 
suggested that Ae. albopictus might be playing a greater role in LACV transmission in 
eastern Tennessee than elsewhere, e.g. Wisconsin.  No statistical difference was found in 
the burden of Ae. triseriatus around residences of LACV cases and non-cases.     
Prevalence 
To determine the prevalence of LACV in eastern Tennessee, serum samples 
originally collected from Knoxville and the surrounding 15 counties to test for 
Treponema pallidum, HIV, and rubella virus were tested for LACV in 1999 [7].  Serum 
samples from 1000 patients were screened for the presence of IgG antibodies, with a 
cutoff of 4.  Those specimens with a final titer of ≥ 8 were considered positive.  Results 
showed a prevalence of 0.5 percent in the samples tested.  The authors concluded that due 
to the low prevalence, LACV was most likely newly endemic to Tennessee, though this 
conclusion should be interpreted with caution as sample specimens came from a biased 
group.  The true extent of LACV prevalence in eastern Tennessee is unknown. 
Early work in the Cherokee Indian Reservation in North Carolina found a 
prevalence rate of LACV in high school students of 11.3 percent [36].  Recent work by 
Szumlas et al. [37] has shown a prevalence of up to 20.6 percent on the Cherokee Indian 
Reservation.  Samples taken in areas outside the reservation indicated a prevalence of 
only 4.7 percent, and is higher than the 0.5 percent prevalence in eastern Tennessee.  No 
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serosurvey has been conducted in West Virginia to date, but it is likely that prevalence in 
the population is similar or higher to that of North Carolina due to the large number of 
reported cases. 
Surveillance for LACV was expanded in eastern Tennessee in 2003 to include the 
trapping and testing of host species for the presence of LACV neutralizing antibodies 
[38,39].  These studies were conducted on populations of the eastern grey squirrel, 
Sciurus carolinensis, and the eastern chipmunk, Tamias striatus, at two sites (A and B) in 
eastern Tennessee from 2003 to 2005.  Site A had two cases of human LACV infections 
previously reported, and was located in Knox County, Tennessee.  Site B had no 
previously reported cases of LACV infections, and was located in Blount County, 
Tennessee.  Four S. carolinensis and two T. striatus collected at site A, had detectable 
levels of LACV neutralizing antibodies during the study period, accounting for a 
prevalence of 2.65 percent.  A single T. striatus collected every year of study period at 
site A, had demonstrated detectable LACV neutralizing antibodies for 717 days, the 
longest recorded persistence of LACV antibodies [28,39,40].  One S. carolinensis 
collected at site B during the last collection week of 2005, had detectable levels of LACV 
neutralizing antibodies, accounting for a prevalence during the study period of 0.44 
percent.  The detection of neutralizing antibodies to LACV in the T. striatus collected at 
site B during the last collection in 2005 could be an indication of recent introduction of 
LACV to this site, and highlights the possibility of virus expansion into areas previously 




Studies in both states provide the most current picture of LACV infections 
[6,8,16,41] and provide clues to the severity and course of the illness.  The majority of 
LACV infections in Tennessee and West Virginia occur in the summer months, in males, 
and in children 15 years and younger [10,16,30,41], these finding agree with reports from 
previous studies elsewhere [2,5,42]. 
The most complete description of the clinical course of LACV infections came 
from a retrospective study of 127 patients with confirmed cases of LACV infections from 
1987 to 1996 in West Virginia [8].  On admission, both vomiting (p = 0.05) and a 
Glasgow Coma Scale score of 12 or lower (p = 0.05), were found to be significantly 
higher for patients with LACV infections than other patients.  LACV patients 
experienced a variety of symptoms: 70 percent experienced headache, fever, and 
vomiting; 46 percent suffered seizures, 42 percent experienced disorientation, 21 percent 
developed hyponatremia, and 13 percent developed increased intracranial pressure.  
Decreases in serum sodium levels (p = 0.01) and increased body temperature (p = 0.01) 
indicated deterioration.  Neurological deficits were recorded in 12 percent of patients at 
the time of discharge, and follow-up assessments showed cognitive and behavioral 
deficits 10 to 18 months post infection. 
Results from the Tennessee case control study [16], found no statistically 
significant (p > 0.05) differences in the presence of fever, headache, vomiting, or 
behavioral changes between the two groups.  Though a later study in Tennessee [41], 
found that LACV patients were significantly more likely than enteroviral central nervous 
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system (EV-CNS) infections to have aphasia (p = 0.001), loss of consciousness (p = 
0.001), seizure (p = 0.001), and admission to a pediatric intensive care unit (ICU) (p = 
0.05). 
Though most infections are asymptomatic or result in a relatively mild febrile 
illness in humans, in a sub-group of patients‟ disease progresses to severe meningitis, 
encephalitis, or meningoencephalitis [8,43,44,45].  Following the course of illness variety 
of sequelae have been reported in the literature [8,45,46]. 
Summary 
The Appalachian region of the United States has shown significant increase in the 
reported cases of LACV infections in the last 20 years (CDC unpublished), with both 
Tennessee and West Virginia experiencing a large increase in the number of reported 
infections in recent years.  Several previous studies in both states have provided insight 
into the risk factors, vector species, prevalence, and the clinical presentation of LACV 
infections, but several questions remain: are there areas of significant disease clustering; 
what is the overall risk of infection in these states; have the risk factors for infection 
changed from previous studies; what are the current vector ecosystem dynamics at case 





        
Virus 
La Crosse virus (LACV) belongs to the family Bunyaviridae, genus 
Orthobunyavirus, and is a member of the California serogroup of viruses.  The viron is 
approximently 90-100 nm in diameter.  The genome of LACV is tri-segmented being 
comprised of single-stranded RNA segments of negative polarity grouped according to 
size: large (L), medium (M), and small (S) [47].  These segments form helical 
ribonucleoprotein complexes (RNPs) within the nucleocapid (N) protein.  The L segment 
encodes for the viral polymerase the source of transcription and the replication of the 
genome [48,49]. The M segment encodes the Gc (formerly G1) and Gn (formerly G2) 
surface transmembrane glycoproteins [50] and NSm (function unknown) through a single 
open reading frame.  Gc and Gn appear to serve as a heteromultimer following cleavage 
of the polyprotein [51].  Following the location by Gn this heteromultimer targets the 
Golgi apparatus; the location of both viral assembly and budding [51,52,53].  Gc is the 
viral attachment protein, serves as the binding site of the neutralizing antibodies, and 
mediates pH-dependent fusion serving as a class II fusion protein and is likely serves as a 
fusion peptide [54,55,56,57] [53,58,59,60].  The S segment encodes for the viral 
nucleocapsid (N) protein and the non-structural protein NSs [61,62,63].  The N protein in 
turn encapsulates the RNA segments and the non-structural protein NSs which suppresses 
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RNA inference, playing a role in invertebrate antiviral defense [64,65], and may have 
evolved to suppress the mammalian innate immune response [66]. 
 
Genotypes 
Three isolates of LACV have been made in humans from post mortem brain 
tissue; Minnesota in 1960, Wisconsin in 1978, and Missouri in 1993 [67].  The remaining 
isolates all originiated from mosquito species.  Huang et al. [67] demonstrated that fatal 
cases of severe LACV infections may come from a narrow range of highly conserved 
genotypes.  Previous studies using DNA fingerprinting of LACV isolates grouped LACV 
strains into three genetic groups A, B, and C [68,69], and recent data suggests that there 
are three distinct lineages of LACV [70].  Groups A, B, and C corresponding to lineages 
1 and 2, with lineage 3 being a distinct group following analysis of the Connecticut 
isolate (6716-05) [70].  It is unknown if these lineages exhibit differences in virulence, 
infectivity, and host specificity. 
Virus Evolution 
Evolution of LACV most likely occurs through antigenic drift and antigenic shift 
(RNA segment reassortment), both of which are common during persistent infections 
[71].  Antigentic drift has been demonstrated in LACV with no two isolates sharing 
oligonucleotide fingerprints [68,69], and is likely the main mechanism for evolutionary 
change within the virus.  The nature of transovarial transmission (TOT) within infected 
vectors would increase the chances of genetic diversity within vector populations as 
 
 16 
reassortment could occur in the infected ovaries following infections of secondary viruses 
[72]. 
Antigenic shift has been demonstrated in vitro, vivo, and in nature [71,73], and 
only viruses within the serogroup appear capable of reassortment [74,75].  Both the 
vector and vertebrate hosts could serve as sites of possible reassortment in nature [72], 
though reassortment has not been demonstrated in animal models and its rate in nature is 
unknown [71,74].  Within the vector populations‟ reassortment has been shown to occur 
at a high level.  Reassortment occurs when the vector becomes infected with a second 
virus within one to two days post infection of the initial virus; by day three the vector 
becomes refractory to superinfection [74].  Interrupted feeding would increase the chance 
that a vector could become infected with several viruses [71].  During this practice the 
vector would take a bloodmeal from several different hosts in a relatively short period of 
time.  Providing that the hosts were viremic with different viruses of the same serogroup, 
reassortment could occur. 
Reassortment is also likely to occur through TOT.  Transovarially infected (TI+) 
mosquitoes have been shown to experience lower virus titers in all tissues than those 
mosquitoes infected through the oral route [72].  Borucki et al. [76], found that 20 percent 
of mosquitoes that were TI+ became superinfected following ingestion of bloodmeals 
containing wild-type LACV or Snow Shoe Hare virus (SSHV).  Of the genomes tested: 
2.3 percent experienced reassortment, and 4.0 percent were shown to be heterodiploid.  
As the females mosquitoes are infected for life each additional bloodmeal would increase 
that chances of reassortment occurring in the ovaries, whereupon the new genotypes 




After ingestion of an infective blood-meal LACV infects and replicates in the 
epithelial cells of the culicine midgut [25,77].  The virus escapes the midgut whereupon it 
infects the hemocoel; it then infects and replicates the neural ganglia, heart, fat bodies, 
ovaries and finally the salivary glands between day 7 to 16 [72,77].  The virus reaches 
high titers in the salivary glands and is passed to the host during the act of feeding.  
Infection and infectiveness of the vector is life long.   
LACV infects ovaries by which it is passed by to the progeny [78,79].  Both male 
and female progeny are infected through this process; infected males are then able to 
infect uninfected females through venereal transmission via accessory sex fluid gland 
fluid [26].  The virus overwinters via TOT [71,80], which appears to cause no negative 
effects on the oocyte and/or the embryo [77], demonstrating a unique co-evolution 
between the vector and virus.  
Virus Isolations from Invertebrates 
LACV has been isolated from the mosquito species Ae. triseriatus [20,81], Ae. 
albopictus [17],  Ae. canadensis [31], Ae. communis [82], An. punctipennis [12], Ae. 
sollicitans [12], Ae. trivittatus [12],  Ae. vexans [12],  Coquillettidia perturbans [12], and 
Culex pipiens [83].  Additionally, LACV has been isolated from the horse fly Hybomitra 
lasiophthalma [84].  Aedes japonicus has been shown to be a competent laboratory vector 




Historically, Ae. triseriatus, a species native to North America, has been the 
primary vector of LACV for much of the United States [2,21].  LACV can be transmitted 
transovarially and venereally in this species and is able to overwinter in eggs 
[4,21,22,26,85].  It is primarily a tree-hole mosquito, but will also oviposit in man-made 
containers. It is known to feed on a variety of mammals including deer, squirrels, 
chipmunks and humans [86].  Aedes triseriatus is widely distributed throughout the 
eastern United States [87] and has been found at LACV case sites in eastern Tennessee 
[16].  Aedes triseriatus likelihood of involvement in the horizontal transmission cycle, 
coupled with its higher midgut infection and dissemination rates of LACV through oral 
infection [88], make it the likely primary vector of LACV in the eastern United States. 
Accessory Vectors  
Aedes canadensis is considered an accessory vector of LACV [9,12,31].  Though 
infection rates similar to those found in Ae. triseristus have been found in both Ohio [12] 
and West Virginia [9], it remains less efficient at transmitting the virus than Ae. 
triseriatus [32].  Aedes canadensis is typically thought to have one generation per year in 
northern areas, though second generations have been reported in Ohio [31].  Warmer 
temperatures in the southern United States would increase the likelihood of several 
generations occurring in one season and thus increasing its involvement in LACV 
transmission. 
Aedes albopictus, an invasive species, is considered to be a probable accessory 
vector of LACV, following laboratory and field studies [16,17,23].  Larvae of Ae. 
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albopictus were discovered in Houston, Texas in 1985 [89] and is believed to have been 
introduced to the United States through shipments of tires from Asia [90,91].  Since its 
establishment, Ae. albopictus has spread over a large portion of the United States [92].  
Its larvae are found in both man-made containers and tree holes. Aedes albopictus is 
known to feed on a variety of animals, including humans [93].  LACV has been isolated 
from Ae. albopictus in eastern Tennessee [17].  It is probable that Ae. albopictus serves as 
an accessory vector, and that its high abundance and aggressive biting may overcome its 
shortcomings in its potential to acquire, develop, and transmit LACV. 
Aedes japonicus, another invasive species, was recently introduced into the 
United States from Asia [94].  Since its introduction into the United States in 1999 
[95,96], it has spread rapidly across the United States.  Aedes japonicus has been shown 
to be a competent laboratory vector of LACV [24], and though this species has 
established in LACV endemic regions [95,97,98,99], its current role in the maintenance 
and transmission of LACV remains unknown.  To date there are no reported isolations of 
LACV from this species. 
It is unknown what the overall role several culicid [12,82,83] and one tabanid 
species [84] play in the transmission and maintenance of LACV, though due to the low 
number of virus isolations, host-feeding preferences, and abundance at LACV foci, it is 
likely that these species play little or no role in virus transmission. 
Virus/Host Relationship 
LACV has been isolated and studied in several species [28,100,101,102,103], but 
the preferred animal model for studying LACV pathogenesis remains suckling mice 
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[104].  LACV isolates inoculated subcutaneously in mice have been found first replicate 
muscle tissue with viremia developing, whereupon the virus crosses the vascular 
endothelial cells and invades the brain [104,105,106,107].  Neurons have been shown to 
be the predominately-infected cells in the CNS [66,104].  As in humans, pediatric mice 
are more susceptible to severe LACV infections than adults [104].  Following, the finding 
that LACV can infect via the nasal route [103], the authors reiterated the hypothesis that 
exposure to water containing LACV infected larvae or free virus from lysed larvae, could 
pose an alternate route nasal/oral for transmission of the virus to host species [108].  This 
hypothesis remains to be tested but would have implications to virus maintenance and 
amplification if found to be a viable alternate route of transmission. 
Hosts 
LACV maintenance is assisted in a horizontal transmission cycle involving the 
primary vector Ae. triseriatus and the primary amplification hosts the eastern chipmunk 
Tamias striatus, the gray squirrel, Sciurus carolinensis, and the fox squirrel, Sciurus 
niger [4,25,27,28].  These species show no clinical manifestations associated with 
infection and are viremic for 1 to 2 days [109,110].  Infection provides them with lifelong 
immunity to the virus [111].    
Secondary hosts, including the red fox, Vulpes fulva, and the gray fox, Urocyon 
cinereroargenteus [112], may spread LACV to non-endemic foci through movement into 
new areas.  The deer mouse, Peromyscus maniculatus, and the white-footed mouse, P. 
leucopus, do not experience significant viremias [112,113] and similarly domestic 
animals have not been shown to become viremic post exposure [4]. 
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Aedes triseriatus is known to feed on a variety mammals including deer, squirrels, 
chipmunks, and humans [86,114], while Ae. albopictus is considered a catholic feeder 
and is known to feed on a diverse range of mammalian, avian, and reptilian species 
[93,114,115].  The differences in feeding behaviors between these two species coupled 
with differences in vegetation/habitat preferences would make it more likely that a higher 
proportion of Ae. triseriatus would come in contact and to feed on the primary 
amplification hosts, Tamias striatus, Sciurus carolinensis, and Sciurus niger [4,25,27,28].   
Geographic Distribution, Incidence, and Environmental Risk Factors 
LACV infections have been reported in 28 states in the eastern United States [70] 
since its recognition in 1964 as a cause of human illness [116], and has traditionally been 
associated with forested areas in the upper-midwestern United States [4,5,117].  There 
have been an average of 79 nationally reported cases of LACV infections per year since 
1964 (CDC unpublished), though pockets of higher infection risk have been reported 
[13].  The majority of cases reported occur during the summer months (June, July, and 
August) [2,29,118].  From 1964 to 1981, there were 1348 cases of California encephalitis 
(LACV) in the United States of which 88.8 percent came from the upper-midwestern 
states of Ohio, Wisconsin, Minnesota, Illinois, and Iowa [5], while only 2 percent came 
from the Appalachian region of the United States (North Carolina, Tennessee, and West 
Virginia).  Recently, LACV infections have been recognized as an emerging disease in 
the Appalachian region of the United States [6,8,9].  
The geographic distribution of the virus is focal [11,13,14,119,120,121], 
coinciding with the presence of the virus, vector species, and amplification hosts 
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[2,4,17,20,21,25,27,28,31,81,82,86,114].  The proximity to hardwood forests and their 
associated tree-holes as well as artificial containers are well-documented risk factors for 
disease transmission [11,16,22,30,117,122].  It is probable that a large percentage of the 
reported cases of LACV infections occur in the peridomestic areas, following human 
encroachment into disease foci [11,14,29].  The recent establishment of two possible 
accessory vector species, Ae. albopictus, and Ae. japonicus, into LACV endemic regions 
could result in an increase the transmission and/or maintenance of the virus within 
peridomestic areas and/or hardwood forests [6,16,17,19,38,97,123], and could result in an 
expansion LACV distribution. 
LACV was first isolated in 1964 [1], and has become one of most common causes 
of pediatric arboviral infections in the United States [2,3].  The majority of cases occur in 
children 15 years and younger [4,5,29,118], with approximately 64 percent of these cases 
occurring in males [5].  The incidence risk in children 15 years and younger is believed to 
be 20 to 30 cases per 100,000 persons in endemic areas, with a case fatality rate of less 
than 1 percent [5,8,118].  However, the true incidence of LACV infections is unknown as 
cases are typically under diagnosed, under-reported, and some are asymptomatic 
[2,13,29,36,124].  
At present the majority of cases of LACV infections remain undiagnosed [2].  
From the results of serosurveys conducted in endemic regions it is clear that the risk of 
asymptomatic infections are much higher than symptomatic infections, with estimates of 
asymptomatic infections to clinical infections in pediatric populations ranging from 2:1 to 
1500:1 [13,36,124].  The high percentage of asymptomatic infections remains unclear, 
but results from a recent study [103], provide further evidence that dose of virus and 
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immune response may responsible for the severity of infection.  Previous work on 
histocompatibility antigens in LACV endemic areas [125], supports this hypothesis.  The 
incidence of LACV infections is therefore much higher, as only the most severe cases 
typically present for medical care and hence get reported.  The results from these studies 
suggest that there are most likely several hundred thousand infections per year in the 
United States [13,36,124]. 
Clinical Overview 
Clinical Presentation 
LACV is typically responsible for a relatively mild febrile illness in humans, 
though in a sub-group of patients LACV may result in the development of severe 
meningoencephalitis [8,43,44,45].  In these patients following the development of febrile 
illness, there is may be a progressive decline in mental status, with symptoms such as 
obtundation, grand mal seizures, coma, and death [29,118].  Following the development 
of coma, recovery has been associated with a variety of neuropsychiatric sequelae, 
including: neuromotor retardation, developmental retardation, permanent seizures, and 
personality disorders [8,43,44,45,126,127,128,129,130].  
It is likely that the vast majority of patients suffering from LACV infections never 
present for medical treatment.  Those presenting for medical treatment have a febrile 
illness, associated with myalgias, fever and headache, and are most likely diagnosed as 
having a viral syndrome [8,41,45,46].  No specific treatment is provided for these 
patients, and only a small subgroup are hospitalized.  Initial evaluations frequently 
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demonstrate elevation of white blood cell (WBC) count together with headache.  These 
findings raise suspicion of bacterial meningitis, tick-borne diseases, or other nonspecific 
viral syndromes.  Most patients recover within a few days and are released without any 
specific treatment or need for long-term follow-up. 
A small subset of patients develop a progressively severe illness.  This is 
frequently heralded by the development of hyponatremia [8], most likely as a result of the 
syndrome of inappropriate antidiuretic hormone secretion (SIADH).  The decline in 
serum sodium is associated with a decline in clinical condition, and hyponatremia has 
been found in 22.6 percent of patients who had a serum sodium of less than 132 mmol/L 
[8].  Other factors associated with a decline in clinical status include vomiting, seizures at 
the time of hospitalization, and a temperature of greater than 38.5°C [8,45].  Vomiting 
has been shown to have a strong correlation with a decline in neurological status and is 
likely due to the development of encephalitis [8].  Close clinical monitoring and 
intervention in patients with suspected LAC encephalitis includes serial monitoring on 
the Glasgow coma scale, with early admission to the ICU for all patients with confusion 
or disorientation.  A Glasgow coma scale score of 8 or less may be an indication for early 
endotrachel intubation.  This subgroup of seriously ill patients need close monitoring in 
an intensive care setting.   
Hyponatremia may be an indication of SIADH and may indicate raised 
intracranial pressure [8,131], and evidence of increased intracranial pressure and resultant 
central nervous system herniation may be associated with encephalitis.  Mechanical 
ventilation with intracranial pressure monitoring may be necessary in these patients.  No 
published studies have been performed to evaluate the benefits of intracranial pressure 
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monitoring, though measures necessary to control elevations of intracranial pressure have 
been used in the management of this clinical emergency [8,131].  These measures have 
included hyperventilation using a mechanical ventilator, in combination with drugs to 
reduce intracranial pressure.  
Seizures are a manifestation of severe LACV infections, and are most likely a 
result of encephalitis associated with increased intracranial pressure.  In an early clinical 
study [43], 51 percent of patients developed seizures, 34 percent suffered grand mal 
seizures and 17 percent suffered focal seizures.  Six patients developed paralysis during 
encephalitis, all but one resolving by the time of discharge.  Of those patients who 
demonstrated seizures at the onset of illness 33 percent had permanent seizures as a 
sequela.  Most other neurologic symptoms resolved by the time of discharge.  In a more 
recent study reviewing 127 children with severe LACV infections [8], 66 percent had 
abnormal electroencephalograms (EEG), 46 percent had seizures, and 2 percent had 
episodes of status epilepticus.  Central nervous system herniation was present in 2 percent 
of patients. 
In 2001, a blinded case control study of suspected central nervous system viral 
infections was performed in eastern Tennessee [16].  Patients in the study received 
lumbar puncture, and bacterial meningitis was excluded.  Serology was performed for all 
major viral groups both on both sera and cerebrospinal fluid.  Diagnostic confirmation of 
infection was determined by performing paired acute and convalescent sera, and the 
interpretation of the tests was made using standard guidelines [132].  There were no 
statistically significant differences in the presence of fever, headache, vomiting, or 
behavioral changes between the two groups.   
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Following the earlier case control study [16], a study to compare the clinical 
symptoms between LACV infection and enteroviral central nervous system (EV-CNS) 
infections in was carried out in eastern Tennessee [41].  Symptoms in the patients with 
LACV infection included elevated temperature, headache, photophobia, vomiting, and in 
severely ill patients, aphasia, seizures, and coma.  None of the patients with EV-CNS 
infections suffered aphasia, loss of consciousness, or seizures. Only one patient with an 
EV-CNS infection required ICU admission. Of the LACV patients, the following 
complications were described: aphasia in 33 percent, loss of consciousness in 40 percent, 
seizures in 40 percent, ICU admission in 27 percent, and requiring mechanical ventilation 
in 13 percent. LACV were significantly more likely than EV-CNS infections to have 
aphasia (p = 0.001), loss of consciousness (p = 0.001), seizure (p = 0.001), and admission 
to a pediatric ICU (p = 0.05). Though some clinical similarities exist, LACV infections 
are associated with significantly higher morbidity than non-polio virus EV-CNS 
infections. 
Laboratory Abnormalities 
Many viral infections are associated with reduced white count and absolute 
lymphocytosis.  Patients with LACV infections have experienced WBC counts from 
peripheral blood ranging from 6.8 K to 49K [8,43,45].  Many of these patients 
demonstrated a significant number of polymorphonuclear leukocytes, representing 50 
percent or more of the total WBC.  These findings make it difficult to establish a clear 
working diagnosis, and are more suggestive of a white count seen in bacterial meningitis. 
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Cerebrospinal fluid (CSF) counts in the majority of patients presenting with 
severe LACV infections are abnormal.  In one study [43] of 35 patients, 89 percent had 
white cell counts ranging from 6 to 300; 14 percent had less than 50 percent lymphocytes, 
and 89 percent had protein levels ranging from 68 to 83 mg/dL.  In a later study [45] of 
48 patients, the range of white cells in the CSF was 0 to 600 cells, and of these 66 percent 
were mononuclear, and 31 percent were polymorphonuclear leukocytes.  CSF protein 
levels were elevated in 30 percent of patients, though none demonstrated a low CSF 
glucose level.  In the most recent study involving the largest case-series to date [8], the 
CSF white cell count ranged from 2 to 867, with lymphocytes predominating in most 
cases; 25 percent of these cases also demonstrated significant red cells in the CSF.  Initial 
lumbar puncture findings ranged from normal to abnormal.  However, by the third day of 
the illness, significant elevations of white cells in the spinal fluid existed in most patients. 
These findings illustrate the wide variation in the number and distribution of white cells 
present in the CSF of patients suffering from LACV infections.  These findings also 
indicate that many samples will contain polymorphonuclear leukocytes, raising early 
suspicion of early bacterial meningitis.   
Diagnosis 
Confirmed and probable cases of LACV infections are required to meet both the 
clinical and laboratory requirements set by the Centers for Disease Controls and 
Prevention‟s case definition for neuroinvasive domestic arboviral diseases [132].  
The most important factor in establishing a diagnosis of LACV infections is an 
index of suspicion eg. time spent outdoors, presence of mosquitoes.  Additionally, 
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physicians need to be aware of any clusters of cases consistent with LACV infection. 
This is particularly important as clusters of cases may occur within a given county or 
township [11,14]. 
Hemagglutination-inhibition (HI) tests are the most likely reliable means of 
establishing a diagnosis in a patient suffering from LACV infection, but only after 5 days 
[133,134].  Unfortunately, these tests are frequently delayed and hinder making an early 
diagnosis.  The presence of IgM, with the absence of IgG is an indication of acute 
infection.  A fourfold rise in titer drawn 4 to 6 weeks following the initial titer provides 
confirmation of this diagnosis.  High titer IgG tests are an indication of recent infection 
usually having occurred within the past 3 to 6 months.  Complement-fixation (CF) titers 
are relatively insensitive in establishing early diagnosis of this disease and should never 
be used alone in establishing the diagnosis of LACV infections [133].  HI, CF, and 
neutralization plaque reduction assay results showed that neutralization assay was the 
most sensitive, followed closely by HI reaction [133].  An IgM titer equal to or greater 
than 1:8 is considered positive in making a presumptive diagnosis.  Only neutralization 
assay and HI reliably showed IgM titers of greater 1:8 within the first 5 days and would 
provide for a presumptive diagnosis of infection [133]. 
More recently, enzyme-linked immunosorbent assay (ELISA) using an IgM 
capture assay, performed by state health departments and the CDC, has been utilized to 
provide rapid diagnosis.  The advantages of these tests are that they provide a high 
sensitivity and specificity, and can be used to screen large numbers of samples.  
Currently, the only FDA commercially approved test for LACV is an indirect 
immunofluorescent assay for IgG and IgM antibodies (Focus Diagnostics, Cyprus, CA).  
 
 29 
The specificity of this assay is 100 percent, and the sensitivity has been shown to be 83 
percent at the time of admission, rising to 93 percent if a second sample was provided 
within 5 days [118].  This test can be performed rapidly and is effective in making an 
early diagnosis of LACV infection.  The disadvantage of this test is that health 
departments or reference laboratories typically perform it, as most hospital laboratories 
will not perform this test due to its associated cost. 
CSF viral cultures are an extremely poor means of identifying this virus.  
Numerous studies demonstrate that the isolation of this virus from spinal fluid is difficult 
[45], therefore samples of spinal fluid submitted for culture are unlikely to be beneficial 
in establishing a diagnosis.  ELISA assay of CSF using IgM capture has been used in 
establishing diagnosis [135].  Unfortunately, no commercially available test using PCR to 
identify LACV infections in humans is available at this time, though recent studies have 
demonstrated its utility [136,137]. 
Severe LACV infections have traditionally proved difficult to distinguish from 
herpes simplex meningoencephalitis and may mimic this disease with similar findings on 
clinical presentation, CSF analysis, EEG, CT scan, and MRI [29,138,139].  A failure to 
respond to treatment for herpes simplex encephalitis, or a negative CSF PCR for herpes 
simplex virus [138], may be an indication to perform additional studies for LACV.  In 
another case results of a brain biopsy performed that showed perivascular mononuclear 
infiltrates and focal aggregates, suggesting viral encephalitis [8,131].  Symptoms in this 
case did not suggest herpes simplex encephalitis, though the indirect immunofluorescent 
monoclonal antibody test to LACV was positive on brain tissue.  In an 
immunocompromised patient thought to have Herpes simplex meningoencephalitis and 
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who demonstrated negative PCR for Herpes simplex virus, convalescent serology 
confirmed the diagnosis of a recent LACV infection [139].  Owing to the similarity of the 
clinical and radiologic findings of encephalitis in patients with Herpes simplex virus and 
LACV infections during the summer months in endemic areas for LACV, CSF analysis 
should be submitted for both Herpes simplex virus and LACV.  Serologic evaluation for 
LACV should be simultaneously submitted. 
In an early study [128], during acute infection, seizures occurred in 56 percent of 
hospitalized patients with 13 percent demonstrating persistent seizures.  During a one 
year follow-up of group of 32 patients with confirmed LACV infections and 13 probable 
infections, 49 percent of patients EEGs were normal, 33 percent were abnormal, and 15 
percent indicated abnormalities that were not diagnostic of a seizure disorder.  In a more 
recent study [8], 90 patients underwent EEG with 66 percent were found to be abnormal, 
focal slowing occurred in 17 percent, lateralization occurred in 9 percent, and focal 
abnormalities in 3 percent.  Those patients with lateralization showed focal abnormalities 
overlying the temporal lobe.  Twenty-eight percent demonstrating results similar to those 
present in patients with Herpes simplex encephalitis.  The presence of these findings, 
together with radiographic evidence and clinical findings, are consistent with the 
diagnosis of Herpes simplex encephalitis. This may delay the diagnosis of severe LACV 
infections. 
EEG in patients with LACV often provided evidence of focal changes that may be 
indistinguishable from those of Herpes simplex encephalitis [8].  These findings, together 
with abnormalities on CT scan of the brain, or MRI study, may provide confusion in the 
clinical diagnosis between LACV and Herpes simplex infections.  EEG therefore 
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provides confirmatory evidence of a significant brain lesion, but provides no specificity 
of diagnosis. 
In a recent study [130], a group of children suffering from periodic lateralizing 
epileptiform discharges (PLEDS) were evaluated.  PLEDS patients remain a small 
subgroup of LACV infection patients, but the results showed that this subgroup of 
patients had a higher incidence of permanent sequelae including: permanent seizures, 
developmental issues, and other neurological complications.  The need for more 
aggressive life support was necessary in 88 percent of these patients, while only 21 
percent of patients without PLEDS needed such aggressive management.  The length of 
critical care was also prolonged in PLEDS patients.  
Treatment 
Patients who early in the illness suffer from seizures, altered mental status, 
vomiting, hyponatremia, and have temperatures of greater than 38.5°C, should be 
monitored extremely closely, preferably in an ICU.  Hyponatremia is usually a 
manifestation of SIADH and is frequently associated with the early development of 
encephalitis.  This group of patients should be considered medically unstable and 
monitored in an ICU [8,43,45,139], and these patients may fall into a group who are 
indistinguishable from acute Herpes simplex meningoencephalitis [138].  Development 
of focal neurologic signs and intractable seizures may well be associated with a rise in 
central nervous system pressure.  Monitoring with an intracranial-pressure monitoring 
device may allow for aggressive management of elevated intracranial pressure using 
osmotic agents and hyperventilation [8,118].  The mainstay of current therapy is 
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aggressive life support, maintenance of adequate electrolyte balance, early detection and 
prevention of hyponatremia, mechanical ventilation, and placement of a intracranial-
pressure monitoring device when needed [29,118].  
Currently, there are no clinically approved medications to treat LACV infections. 
From the limited body of knowledge it appears that ribavirin may be a treatment option 
for LACV infections [131,140].  Based on in vitro studies where ribavirin was shown to 
be active [140], the drug was made available as a compassionate release by the FDA for 
patients suffering from life-threatening LACV infections.  Anecdotal evidence suggests 
that this may have been beneficial in a few patients, but experience is limited [131]. 
The most likely target of ribavirin in LACV infections is RNA-dependent RNA 
polymerase, with an in vitro minimum inhibitory concentration (MIC) of 0.3 µmol/L 
[140].  This level is achievable, and high dose oral therapy has obtained levels of 9.5 
µmol/L in the CSF [141,142].  In a previous study evaluating the use of ribavirin in HIV 
infected children, it was demonstrated that doses of 10 mg/kg per day of oral ribavirin 
resulted in steady state plasma levels of 4 µmol/L [143].  These levels should be 
therapeutically effective in the treatment of LACV infections.  
Timely therapeutic intervention would have the potential benefit of reducing the 
severity of illness produced by LACV, including its most serious complications. The use 
of oral ribavirin as a treatment of LAC viral infections may be effective due to its known 
anti-viral activity against LACV even in low concentrations [144]. Limited experience in 
treating LAC encephalitis supports this [131,140,145].  Additionally, if it oral ribavirin 
was found to be an effective treatment for LACV infections it would have an advantage 
over intravenous ribavirin as it is a commercially available product, thus allowing for 
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early administration and treatment. 
Sequelae 
 
Severe LACV infections can result in a variety of sequelae, including seizures, 
learning disabilities, cognitive deficits, and behavioral changes [8,45,46].  A recent study 
[8], found that 36 percent of patients had IQ scores ≤ 79.  An early study in Wisconsin 
found that there were twice as many patients permanently institutionalized for mental 
disorders with LACV antibodies, than in the general population [146].  Furthermore, 
when those patients with physiological cerebral defects were excluded from the analysis, 
the rate increased to three times as many as compared with the general population.  It is 
clear that a range of debilitating sequelae can result in patients suffering from severe 
LACV infections, and long-term follow-up of this patient group is mandatory.  
Socioeconomic Impacts Associated with Infection 
The socioeconomic impacts of LACV infections are traditionally borne by the 
families and those patients who have suffered from severe LACV infections [4,127], due 
to its focal nature and that the majority of cases are asymptomatic [2].  A recent study in 
North Carolina measured the economic and social impacts of severe LACV infections 
[127].  The projected life-long costs of cases in this study suffering from permanent 
neurological sequelae ranged from $48,775 to $3,090,798, and the loss of 12.90 to 72.37 
disability adjusted life years (DALYs).  DALYs are defined by the World Health 
Organization (WHO) as “a time-based measure that combines years of life lost due to 
premature mortality and years of life lost due to time lived in states of less than full 
health” [147].  These findings of the high economic costs associated with severe LACV 
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infection are in agreement with previous studies elsewhere [121].  LACV patients may 
experience a loss of social interactive skills following the course of illness, resulting in 
the isolation of these patients from their peers [4], leading to difficulties in the school and 
home environments. 
Prevention 
The prevention of LACV infections remains a daunting objective due to its 
complex eco-epidemiology.  Prevention of LACV transmission has been demonstrated 
best in La Crosse, Wisconsin, where following the detection of the virus, a county-wide 
public education campaign was initiated, which also included the source reduction and 
the closure of basal tree-holes to reduce populations of Ae. triseriatus  [14,148,149,150].  
This program greatly reduced the number of reported LACV infections [4,14,148], and in  
those areas without such preventative efforts there was no demonstrated reduction in the 
number of reported LACV cases [148].  Vector species and LACV are widely associated 
with the presence of artificial containers [12,16,17,19,30,34,148,151], though their 
removal remains challenge without funding and public education efforts.  The use of 
mosquito repellants should be used by those in LACV endemic areas [118].  Ultimately, 
the avoidance of wooded areas, artificial containers, vector species, and endemic foci, 
and the use of mosquitoes repellants would reduce the risk of exposure to virus 
[2,4,16,29,30,116,118,148,152].  Future studies are needed to detect areas of highest risk 
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Although La Crosse virus (LACV) is one of the most common causes of pediatric 
arboviral infections in the United States, little has been done to assess its geographic 
distribution, identify areas of higher risk of disease, and to provide a national picture of 
its clinical presentation.  Therefore, the objective of this study was to investigate the 
geographic distribution of LACV infections reported in the United States, to identify hot-
spots of infection, and to present its clinical picture.  Descriptive and cluster analyses 
were performed on probable and confirmed cases of LACV infections reported to the 
Centers for Disease Control and Prevention from 2003-2007. A total of 282 patients had 
reported confirmed LACV infections during the study period. Of these cases the majority 
(81 percent) presented during the summer, occurred in children 15 years and younger 
(83.3 percent), and were found in male children (64.9 percent).  Clinically, the infections 
presented as meningioencephalitis (56.3 percent), encephalitis (20.7 percent), meningitis 
(17.2 percent), or uncomplicated fever (5 percent). Deaths occurred in 1.9 percent of 
confirmed cases, and in 8.6 percent of patients suffering from encephalitis. The majority 
of these deaths were in patients 15 years and younger. The county-level incidence risk 
among counties (n = 136) reporting both probable and confirmed cases for children 15 
years and younger (n = 355) ranged from 0.2 to 228.7 per 100,000 persons.  The southern 
United States experienced a significantly higher (p < 0.05) incidence risk during the 
months of June, July, August, and November then the northern United States.  There was 
significant (p < 0.05) clustering of high risk in several geographic regions with three 
deaths attributed to complications of LAC encephalitis occurring in two of these hot-
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spots of infections.  Both the incidence risk and case fatality rates were found to be 
higher than previously reported. We detected clustering in four geographic regions, a 
shift from the prior geographic distributions, and developed maps identifying high-risk 
areas. These findings are useful for raising awareness among health care providers 
regarding areas at a high risk of infections and for guiding targeted multifaceted 
interventions by public health officials. 
Introduction 
La Crosse virus (LACV) is a member of the genus Orthobunyavirus, family 
Bunyaviridae, and is the causative agent of LACV infections.  LACV was first isolated in 
1964 [1], and has become one of most common causes of pediatric arboviral infections in 
the United States [2,3].  The majority of LACV infections are transmitted to humans 
through the bite of the primary vector, the eastern tree-hole mosquito, Aedes triseriatus 
[20,25].  The virus is maintained in nature through a vertical and horizontal transmission 
cycle involving Ae. triseriatus [21,22,26] and the primary amplification hosts: the eastern 
chipmunk, Tamias striatus, the gray squirrel, Sciurus carolinensis, and the fox squirrel 
Sciurus niger [27,28]. 
LACV has traditionally been associated with forested areas in the upper-
midwestern United States [4], but more recently as an emerging disease in the 
Appalachian region of the United States [6,8,9].  The majority of cases occur in children 
15 years and younger [4,5,29,118], with an average of 79 nationally reported cases per 
year since 1964, pockets of higher infection risk have been reported [13].  The incidence 
risk in children 15 years and younger was believed to be 20-30 cases per 100,000, with a 
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case fatality rate of less than 1 percent [5,8,118].  However, the true incidence of LACV 
infections are unknown as cases are typically under diagnosed, under-reported, and some 
are asymptomatic [13,29,36,124].  In this study, we examined probable and confirmed 
cases of LACV infections from 2003-2007, to determine incidence risk, case fatality 
rates, and to assess the current spatial patterns of disease risk so as to identify those areas 
of highest risk for the implementation of future disease control strategies. 
Methodology 
Study area.  Our study area encompassed the eastern United States, the 
geographic region that includes the majority of previously reported LACV infections and 
the range of the primary vector, Ae. triseriatus [2,5,29,87].  County level incidence risks 
were calculated and spatial analyses performed on 24 states in the study area.  Seventeen 
of the 24 states reported probable and confirmed cases of LACV infections in children 15 
years and younger (Table 1).  The following states were part of the study area but did not 
report any LACV infections in children 15 years and younger during the study period: 
Arkansas, Delaware, Florida, Maryland, Missouri, New Jersey, and Pennsylvania.  All of 
these states have reported LACV infections in the past. 
Disease data.  This study was conducted for all states reporting probable and 
confirmed cases of LACV infections in the United States, 2003-2007, through the 
ArboNET surveillance system [153].  The ArboNET surveillance system was established 
by the Centers for Disease Control and Prevention in 2000 to monitor the spread of West 
Nile virus in the United States.  In 2003, the system was expanded to collect data on other 
arboviral diseases.  Through ArboNET, participating health departments report human 
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cases of arboviral disease.  The ArboNET system was queried to search for all LACV 
infections. 
Personal identifiers of patients were deleted before database construction.  
Clinical and epidemiological LACV data for 151 probable and 275 confirmed cases of 
LACV infections reported during this time period were provided by the Centers for 
Disease Control and Prevention.  Cases that acquired infection outside of the county/state 
were excluded from spatial analyses (n = 10).  
Case definition.  Confirmed cases of LACV infections are required to meet both 
the clinical and laboratory requirements set by the Centers for Disease Controls and 
Prevention‟s case definition for neuroinvasive domestic arboviral diseases [132].  This 
definition is reprinted below: 
 
In the absence of a more likely clinical explanation as 
documented by a physician, confirmed cases must meet all 
of the following criteria: 
Clinical Criteria 
1) Fever, AND 
2) Acutely altered mental status, or other acute signs of 
central or peripheral neurologic dysfunction, or 
pleocytosis associated with illness clinically compatible 
with meningitis, AND  
Laboratory Criteria 
3) a four-fold or greater change in virus-specific serum 
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antibody titer, or isolation of virus from or demonstration 
of specific viral antigen or genomic sequences in tissue, 
blood, CSF, or other body fluid, or virus-specific 
immunoglobulin M (IgM) antibodies demonstrated in 
CSF by antibody-capture enzyme immunoassay (EIA), or 
virus-specific IgM antibodies demonstrated in serum by 
antibody-capture EIA and confirmed by demonstration of 
virus-specific serum immunoglobulin G (IgG) antibodies.  
 
Probable Case Criteria 
Cases that met the clinical definition and had stable (less 
than or equal to a two-fold change) but elevated titer of 
virus-specific serum antibodies, or virus-specific serum 
IgM antibodies detected by antibody-capture EIA but with 
no available results of a confirmatory test for virus-specific 
serum IgG antibodies in the same or a later specimen, are 
deemed probable.   
 
Population and geographic data.  The 2005, United States Census Bureau, 
Estimated County Population Dataset [154], was used to calculate the total population and 
the population 15 years and younger for each county.  These populations were used to 
provide the denominators for calculating incidence risk at the county level.  As the US 
Census Bureau does not provide yearly population estimates that include sex, age, and race 
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for the county level, the 2000 United States Census [155] was used to provide the 
denominators for calculating the sex - age - and race - specific incidence risk for all counties 
reporting LACV infections.  Geographic boundary files were downloaded from the United 
States Census, TIGER, Geodatabase [156], and used for all cartographic displays. 
Statistical and geographic analyses.  Incidence risk was calculated and spatial 
analyses were performed on 123 probable and 232 confirmed cases 15 years and younger 
and on 275 confirmed and 151 probable cases for all ages occurring during the study 
period for which county level data were available (Table 1).  Incidence risk was 
calculated for all counties in the study area (n = 1924) and for counties reporting both 
confirmed and probable cases of LACV infections under the age of 15 (n = 136) and for 
all ages (n = 161).  Incidence risks were expressed as the number of cases per 100,000 
persons. 
To determine if there was a significant difference in incidence risk by month 
between states reporting cases in the northern (n =7) and southern (n= 10) regions of the 
study area, we calculated the incidence risk by region and month using the both probable 
and confirmed cases 15 years and younger.  The northern region was comprised of 
Illinois, Iowa, Indiana, Michigan, Minnesota, Ohio, and Wisconsin.  The southern region 
was comprised of Alabama, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, 
South Carolina, Tennessee, Virginia, and West Virginia. 
All incidence risk computations and descriptive analyses were performed using 
STATA 10.0 [157].  Spatial empirical Bayesian (SEB) smoothing was used to adjust 
incidence risk due to spatial autocorrelation and high variances resulting from a small 




Table 1. Non-Imported Probable and Confirmed Cases and Incidence Risk*of La Crosse Viral 
Infections in Children 15 Years and Younger Reported in the eastern United States, 2003-2007, by 
State 








Range of Incidence Risk 
Amoung Counties 
Reporting Cases 
     
West Virginia 83 23.4 57.8 7.5 - 228.7 
Ohio 73 20.6 5.0 0.3 - 37.1 
North Carolina 66 18.6 21.0 0.5 - 206.7 
Tennessee 50 14.1 18.4 3.6 - 166.6 
Wisconsin 21 5.9 12.1 1.1 - 76.7 
Illinois 18 5.1 1.3 0.2 - 30.8 
Minnesota 9 2.5 10.6 7.3 - 29.8 
Virginia 8 2.3 7.8 1.6 - 35.2 
Georgia 7 2.0 2.6 0.5 - 129.8 
Indiana 6 1.7 2.0 0.5 - 20.6 
Louisiana 4 1.1 6.5 4.0 - 23.2 
Iowa 3 0.8 41.4 27.7 - 55.1 
Kentucky 3 0.8 13.5 7.7 - 23.6 
Michigan 1 0.3 1.0 1.0 
Mississippi 1 0.3 8.3 8.3 
Alabama 1 0.3 0.7 0.7 
South Carolina 1 0.3 1.7 1.7 
Florida
†
 -- -- -- -- 
     
Overall 355 100 7.2 0.3 - 228.7 
     
 
Table 1. * Incidence risk was calculated in counties reporting probable and confirmed cases of La Crosse 
viral infections and presented as the number of cases per 100,000 persons in children 15 years and younger, 
and are expressed here as a range in those states with two or more counties reporting cases.  
†
No incidence risk is reported for states not reporting cases 15 years and younger. 
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 incidence risks allow for better visualization of the spatial patterns compared to the 
unsmoothed risk. 
Global Moran‟s I [162] and the Moran Local Indicators of Spatial Association 
(LISA) were used to assess for evidence of spatial clustering [163].  Statistical 
significance of both global and local Moran‟s I statistics were tested using 9999 
permutations.  All spatial analyses were performed using GeoDa Version 0.95i [164], and 
cartographic displays were done using ArcView GIS 9.2 [165]. 
Results 
Descriptive analyses of cases.  A total of 282 patients had confirmed LACV 
infections reported to the CDC (Table 2).  Most cases presented during July (24.9 
percent), August (32.6 percent), and September (23 percent).  Cases ranged in age from 
0.5 to 86, with a median age of 9; 83.3 percent were under the age of 15, and the majority 
were males (64.9 percent). 
The sex-specific incidence risk (per 100,000 persons) for all counties reporting 
confirmed cases was 1.9 and 1.0 for males and females, respectively.  The age-specific 
incidence risk was 1.2 for children under one year; 5.4 for 1-5 years; 6.8 for 6-10 years; 
4.7 for 11-15 years; 0.5 for 16-20 years; and 0.2 for 21 years and older.  Blacks had the 
lowest race-specific incidence risk (0.3 per 100,000 persons) and American Indians had 
the highest (4.9 per 100,000 persons).  The incidence risk for all counties reporting 
probable and confirmed cases combined in children 15 years and younger was 7.2 per 





Table 2. Epidemiological and Clinical Characteristics of Confirmed and Probable La 
Crosse Viral Infections Reported in the eastern United States, 2003-2007 
   




   
Sex   
     Male         183 (64.9) 264 (60.6) 
     Female 99 (35.1) 172 (39.4) 
     Unknown -- 1 
   
Age   
     0.1 – 0.9 yr   3 (1.06)               5 (1.15) 
     1 yr           11 (3.9)    13 (2.98) 
     2 – 5 yr 59 (20.9)    98 (22.8) 
     6 – 10 yr 98 (34.8) 157 (26.4) 
     11 – 15 yr 64 (22.7)     87 (19.95) 
     16 – 20 yr 7 (2.5)   15 (3.44) 
     ≥ 21 yr 40 (14.2)     61 (13.99) 
     Unknown -- 1 
   
Race   
     White         241 (95.3) 368 (95.6) 
     Black or African American 9 (3.6)   11 (2.86) 
     American Indian or Alaska Native 3 (1.2)     4 (1.04) 
     Asian             0 (0)       1 (0.259) 
     Other             0 (0)       1 (0.259) 
     Unknown 29 52 
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Table 2. *Unknown, represents the number of confirmed and probable cases for which the case outcome was not reported.
   
Month of presentation   
     March  1 (0.35)        2 (0.458) 
     April  3 (1.06)        3 (0.686) 
     May  1 (0.35)        2 (0.454) 
     June           23 (8.2)    29 (6.64) 
     July           71 (24.9)   110 (25.2) 
     August           92 (32.6)   138 (31.6) 
     September           65 (23)   105 (24.0) 
     October           23 (8.2)     44 (10.1) 
     November  2 (0.71)         3 (0.686) 
     December  1 (0.35)         1 (0.229) 
   
Clinical manifestation   
     Meningioencephalitis          157 (56.3) 242 (55.3) 
     Encephalitis 58 (20.7)   78 (17.8) 
     Meningitis 48 (17.2)   87 (19.9) 
     Uncomplicated fever           14 (5.0) 18 (4.4) 
     Other 2 (0.7)    3 (0.7) 
     Unknown 3 8 
   
Death 5 (1.86)      6 (1.43) 
     Unknown* 13 16 
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The incidence risk was significantly higher in the states in the southern region 
than those states in the northern region for June (p = 0.0018), July (p = 0.0002), August 
(p = 0.0033), and October (p= 0.0053).  There were no statistically significant difference 
(p > 0.05) in the incidence risk between the states in the northern and southern regions for 
the months of March, April, May, September, and November. 
Clinically, the infections presented as meningioencephalitis (56.3 percent), 
encephalitis (20.7 percent), meningitis (17.2 percent), uncomplicated fever (5 percent), or 
other (0.7 percent) (Table 2).  Deaths accounted for 1.9 percent of confirmed cases, and 
were reported in Indiana, Michigan, Tennessee, and West Virginia.  All deaths occurred 
in patients suffering from LAC encephalitis (100 percent).  Of those patients presenting 
encephalitis 8.6 percent died.  The majority (80 percent) of these deaths were in patients 
15 years and younger (median age 6, range 4-86) and occurred in males (80 percent).  
Three deaths occurred in the high risk clusters in West Virginia and in Tennessee.  
Spatial distribution.  In children 15 years and younger (probable and confirmed 
combined), state-level incidence risk ranged from 0.7 to 56.4 per 100,000 persons 
whereas at the county-level incidence risk in counties reporting cases, ranged from 0.2 to 
228.7 per 100,000 persons (Table 1).  Geographically, the highest incidence risks were 
observed in western and central Illinois, northeastern Iowa, south central Minnesota, 
southwestern Wisconsin, and the Appalachian region (south central Kentucky, south 
central Ohio, western North Carolina, central and eastern Tennessee, south central West 
Virginia) (Fig 1).  The spatial patterns are more easily recognizable when smoothed (Fig. 
1b) as compared to the unsmoothed incidence risk map (Fig. 1a). The global Morans I 
value for children 15 years and younger, was 0.1904 (p = 0.0001) for only confirmed 
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cases and 0.2223 (p = 0.0001) for both probable and confirmed cases combined.  Forty-
seven of the counties in the study area showed evidence of significant high incidence risk 
(p < 0.05) detected by LISA using confirmed cases, while 54 counties had evidence of 
significant clustering of high risk (p < 0.05) detected using both probable and confirmed 
cases.  The spatial patterns for both confirmed cases and for probable and confirmed 
cases combined were similar.  Therefore, only the spatial patterns using both the probable 
and confirmed cases are presented in Figure 2.  The clusters detected by using both 
probable and confirmed cases combined were found in northeastern Iowa/southwestern 
Wisconsin, and in south central Ohio, western North Carolina/eastern 
Tennessee/northeastern Georgia, and south central West Virginia/eastern 
Kentucky/northwestern Virginia (Fig 2).  County-level incidence risks for counties that 
were part of the significant high clusters ranged from 4.7 to 228.7 per 100,000 persons 
(mean 54.6) in children 15 years and younger. 
Discussion 
Our study provides the first risk map of LACV infections for the United States, 
and presents insights into the clinical picture of LACV infections.  We found both a 
higher incidence risk than previously reported ranging up to 228.7 cases per 100,000 
persons in children 15 years and younger and a case fatality rate of 1.9% [5,7,8]. This 
study highlights the differences of the clinical presentation of LACV infections as 
meningioencephalitis, encephalitis, meningitis, uncomplicated fever, or other; rather than 





Figure 1. Distribution of unsmoothed and smoothed incidence risk in children 15 years and younger. 
The map on the left represents the distribution of a) unsmoothed risk and b) smoothed risk of La Crosse 





Figure 2. Spatial patterns of disease risk in children 15 years and younger. 
This map shows the significant clustering of La Crosse infections at the county level detected by the 
Moran‟s I Local Indicators of Spatial Autocorrelation (LISA) for the eastern United States. Four types of 
spatial autocorrelation are observed using the LISA statistic (High-High, Low-Low, High-Low, and Low-
High). Positive spatial autocorrelation is represented by High-High and Low-Low, and negative spatial 
correlation by High-Low and Low-High. Positive spatial autocorrelation (i.e. an association of areas of 
similar values) were represented as either High-High (i.e. a high risk in an area surrounded by similarly 
high values in neighboring areas) or Low-Low (i.e. a low risk in an area surrounded by similarly low values 
in neighboring areas). Negative spatial autocorrelation (i.e. an association of areas of dissimilar values) was 
represented as either High-Low (i.e. a high rate in an area surrounded by low values in neighboring areas) 
or Low-High (i.e. a low rate in an area surrounded by high values in neighboring areas).
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To our knowledge this is the first use of smoothing techniques, the global 
Moran‟s I, and the Moran Local Indicators of Spatial Association (LISA) to detect spatial 
clustering of LACV infections at a national level in the United States.  We identified high 
risk clusters in four regions of the United States.  These high risk clusters should be 
targeted for future studies and intervention efforts. 
The majority of cases reported occurred in the summer months (June, July, and 
August) in agreement with previous studies [2,29,118], with a significantly higher 
incidence risk occurring in southern states during the months of June, July, August, and 
September.  This is likely due to the transmission cycle of LACV, which involves both 
horizontal and vertical transmission.  The burden of infected mosquitoes would continue 
to increase into the summer months as each successive generation of mosquitoes fed 
upon infective amplification hosts, followed by increased transovarial transmission of the 
virus to their progeny.  The highest risk of infection would thus occur during the height 
of this amplification process when the highest burden of infected mosquitoes would be 
reached.  The height of this viral amplification coincides with the summer months when 
humans are most apt to spend the most time outdoors, thus putting themselves at an 
increased risk for coming into contact with infected mosquitoes. 
Temperature may play a role in higher incidence risk in southern region of the 
United States.  Given that transovarial transmission following one gonotrophic cycle is 
likely rare in nature [21], orally infected Ae. triseriatus, likely need to complete at least 
two gonotrophic cycles to transovarially transmit the LACV to their eggs [166].  As only 
a small percentage of Ae. triseriatus may survive to complete their second gonotrophic 
cycle in nature [166], an increase in the ambient temperature would increase the number 
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of gonotrophic cycles possible in lifespan of a vector.  Additionally, higher temperatures 
would have the added effect of increasing viral dissemination, titers, and transmission in 
vectors [167,168].  Warmer temperatures, which are traditionally present for longer 
periods of time in the southern United States could play a substantial role in increasing 
overall vectorial capacity. 
Previous studies have shown that over 90% of reported cases occurred in children 
15 years and younger [5], with approximately 64% of these cases occurring in males [5].  
Our study confirms these findings with roughly 83 percent of confirmed cases occurring 
in children 15 years and younger and 64.9 percent of these cases occurring in males.  
Clinical studies have demonstrated similar findings [8,43,45].  The tendency for children 
to develop severe LACV infections may be due to a variety of factors including 
differences in the pediatric and adult immune system, and/or the longer time children 
may spend outdoors, though such risk factors are not well understood.  It has been 
hypothesized elsewhere that the higher incidence risk in males may be due to the fact that 
boys tend to spend more time outdoors than girls increasing their risk of contact with 
infective vectors [116,124]. 
Of the 426 reported probable and confirmed LACV infections during our study 
period, the Appalachian region including West Virginia, North Carolina, Ohio, and 
Tennessee reported 22.2 percent, 20.8 percent, 18.5 percent and 22.2 percent of reported 
cases, respectively, and accounted for 74.5 percent of all cases during the study period.  
A previous study from 1964-1981, reported 1348 cases in the United States of which 88.8 
percent came from Ohio, Wisconsin, Minnesota, Illinois, and Iowa [5], while only 2% 
came from North Carolina, Tennessee, and West Virginia.  Though our results 
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encompass only a five-year period, the higher incidence risk in these states may indicate 
a shift in LAC infections from the upper Midwest to the Appalachian region of the 
United States [6,8,9].  The reason for this shift is unclear, but could be due to a number of 
factors including changes in diagnosis, reporting, prevention strategies, as well as 
changes in the epidemiology of the disease. 
Though our finding of an incidence risk of 30.2 per 100,000 persons in children 
15 years and younger in probable and confirmed cases combined was similar to previous 
reports of an incidence risk of 20 to 30 per 100,000 persons in the same age group 
[10,15].  But our finding of a mean incidence risk in the significantly high spatial clusters 
was numerically higher, 54.6 per 100,000 persons, then the incidence risk previously 
reported for the same age group [10,15].  In the individual counties reporting cases of 
LACV infections we found the incidence risk in children 15 years and younger ranging 
from 0.16 to 165.4 per 100,000 persons using only confirmed cases, and from 0.2 to 
228.7 per 100,000 persons using both confirmed and probable cases combined.  These 
results indicate the wide variation that occurs due to the focal nature of the virus within 
counties reporting LACV infections, and highlights the need to report the range of 
incidence risk, rather than reporting only the mean incidence risk which may not provide 
an accurate assessment of risk within these focal areas.  From the results of serosurveys 
conducted in endemic regions it is clear that the risk of asymptomatic infections is much 
higher than symptomatic infections, with estimates of asymptomatic infections to clinical 
infections in pediatric populations ranging from 2:1 to 1500:1 [13,36,124].  The 
incidence of LACV infections are therefore much higher, as only the most severe cases 
typically present for medical care and hence get reported.  The results from these studies 
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suggest that there are most likely several hundred thousand infections per year in the 
United States [13,36,124], but our findings suggest that there are many more cases than 
previously estimated.  The spatial distribution (Fig 1) reaffirms the focal nature of these 
infections, and identifies the areas with the highest risk. 
The use of probable and confirmed cases combined increased overall cluster 
detection from 47 to 54 counties.  The significant high risk clusters detected should be 
targeted for future studies and for interventions by public health officials. 
Reporting the mean incidence risk at the state or county level may lead to a 
distorted picture of the spatial patterns of LACV infections and thus decrease the 
perception of risk.  Future reporting should include the range of incidence risk occurring 
in those counties reporting cases.  This will minimize misperceptions of risk, as the use of 
incidence risk continues to remain the most used tool to identify high risk areas for 
education, prevention, and intervention. 
Though LACV infections are typically reported as LAC encephalitis there appears 
to be four distinct clinical syndromes, as well as asymptomatic infections [2,8,42,43,45],  
These include the most severe LAC encephalitis, LAC meningioencephalitis, LAC 
meningitis, and LAC fever.  It is difficult to assess the true incidence of these syndromes 
since they have often been collectively reported as LAC encephalitis in previous 
reports/studies [43,44,45].  Accurate reporting of the patients‟ clinical syndrome is 
necessary to determine and monitor the future rates of disease presentation. 
Our study found a case fatality rate of 1.9% in confirmed cases, with all of the 
deaths occurring in patients presenting encephalitis.  This finding is much higher than the 
case fatality rate of 0.3% reported in a previous study of LACV infections in the United 
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States [5].  The reason for the higher case fatality rate is unclear, but may be due to a 
variation in virulence in the LACV strain(s) circulating in this region of the United States 
[67].  The majority of these were in children 15 years and younger of whom had 
encephalitis.  These findings suggest that LACV infections might be more virulent than 
sometimes reported in medical literature.  Three deaths (probable and confirmed cases 
combined) occurred in two of the four highly significant clusters of probable and 
confirmed cases of LACV infections in West Virginia and Tennessee. 
Our study has some limitations.  Probable and confirmed cases were reported 
through a passive surveillance system, which inherently suffers under-reporting.  Not 
withstanding this limitation we feel that the majority of cases progressing to severe 
illness were diagnosed and reported to public health officials.  Using only confirmed 
cases as well as probable and confirmed cases combined, we were able to demonstrate 
similar high incidence risk and case fatality rates.  We were also able to show similar 
patterns in disease clustering.  Clinical data was reported from multiple state health 
departments to the CDC, which did not allow for the verification of laboratory results and 
the diagnosis of the specific clinical presentation for each patient.  We feel that this is a 
small limitation and that the majority of cases reported have been correctly separated into 
the four manifestations of severe LACV infections by clinicians. 
One drawback to using the LISA is the issue of multiple comparisons which 
increases type I error rates.  We didn‟t make an attempt to adjust for this because some 
authors have suggested that any adjustments made to reduce the type I errors would 




Our findings of a incidence risk within significantly high spatial clusters and case-
fatality rate indicate a much higher burden of disease than previously reported, and 
demonstrate that LACV infections are much most common than previously reported. We 
have demonstrated the usefulness of these spatial statistical techniques to detect hot-spots 
of infections, thus allowing for targeted interventions by public health officials while 
raising awareness among health care providers of geographic areas at the highest risk of 
disease. 
Our results will allow focused national serological studies, form the basis for the 
development of predictive models of virus transmission, provide a methodology for the 
use spatial analyses at a national level for other infectious diseases, and demonstrate the 
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Focal arboviral infections affecting a sub-set of the overall population present an 
often over-looked set of challenges in the assessment and reporting of risk and the 
detection of spatial patterns.  Our objective was to assess the possible variation of risk 
when using different at-risk populations and geographic scales for the calculation of 
incidence risk and the detection of disease clusters.  We explored these variations using a 
pediatric arbovirus, La Crosse virus, as our model.  Descriptive and cluster analyses were 
performed on probable and confirmed cases of La Crosse infections reported to the 
Tennessee Department of Health from 1997-2006, using three different at-risk 
populations and two geographic levels to assess the variation in incidence risk and to 
investigate evidence of clustering using both global and local spatial statistics.  We 
determined that the most appropriate at risk population to calculate incidence risk, and to 
assess evidence of clustering was 0-15 year old population cohort.  Based on our 
findings, the most appropriate geographical level to conduct spatial analyses and report 
incidence risk was the census tract level.  Our results indicate the possibility of missing 
disease clusters resulting from performing incidence risk investigations of focal diseases 
using inappropriate at-risk populations and/or large geographic scales.  Public Health 
efforts to improve both disease surveillance and health planning would be better 
improved through the assessment of risk in well defined at-risk populations and 
geographic scales.  This ensures that public health efforts to control disease occurrence 




The first step in the control and prevention of pathogen transmission requires the 
identification of the population at-risk.  Early work involved the use of purely 
observational data to identify and prevent disease outbreaks, such as John Snow‟s 
calculation of the risk of death by water supply, leading to the identification of 
“contaminated” water supplies and efforts by the City of London to prevent the drinking 
of water from those sources [170].  Though today we have more advanced technologies 
at our disposal, the underlying principles of determining disease occurrence remain 
roughly the same.  We use the incidence of disease to determine populations at-risk and 
cluster analyses to determine the hot-spots of infections within those populations in an 
effort to interrupt and/or prevent transmission. 
In this study, we explored the variability of incidence risk and investigated 
evidence of clustering, using a focal arbovirus, La Crosse virus (LACV) as our model.  
LACV is a member of the genus Orthobunyavirus, family Bunyaviridae.  It is the 
causative agent of LACV infections, and is the most common cause of pediatric arboviral 
encephalitis is the United States [2,3], with the majority of cases being reported in 
children 15 years and younger [4,5,29,118].  Maintenance and transmission of the virus 
typically occurs in focal wooded areas where the primary vector, the eastern tree-hole 
mosquito, Aede triseriatus [20,21,22,26], and the primary amplification hosts the eastern 
chipmunk (Tamias striatus), the gray squirrel (Sciurus carolinensis), and the fox squirrel 
(Sciurus niger), are in close contact [2,27,28].  Transmission to humans occurs when 
children enter these focal areas and are bitten by infective mosquitoes. 
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LACV has traditionally been associated with the upper-midwestern United States 
[4] though it has been reported in other regions; recently as an emerging disease in 
eastern Tennessee [6,7,16].  There is an average of at least 100 reported cases per year 
[13].  However, the true incidence of LACV infections are unknown as the disease is 
under-diagnosed and under-reported [6], making detection and intervention by public 
health officials problematic. 
From 1964-1996, there were 2370 total cases of LACV infections reported to the 
CDC, with Tennessee reporting 9 cases or 0.38 percent of the total cases.  In 1997, a 
cluster of 10 cases was detected in eastern Tennessee [6], during which time active 
surveillance for the virus was initiated by both the University of Tennessee and The 
Tennessee Department of Health.  During the ten year time period following increased 
surveillance efforts, 1997-2006, Tennessee reported 118 cases, out of the 1069 cases 
reported to the CDC, accounting for 11 percent of all nationally reported cases, marking a 
significant increase in cases for Tennessee from the previous 32-year time period. 
Focal diseases affecting a sub-set of the overall population present an often over-
looked set of challenges in calculating and reporting incidence and the detection of 
spatial patterns.  We explored these unique challenges by examining cases of a focal 
pediatric arbovirus, LACV, in eastern Tennessee to determine the most appropriate at risk 
population and geographic scale to use in the investigation and reporting of disease risk.  
It is hoped that the findings of this study will provide information to public health 
officials and researchers an improved definition of at-risk populations and hence better 
quantification of disease risk.  This information will be useful in guiding health planning 




Study area and disease data.  This study was conducted in eastern Tennessee 
(Figure 3), a region endemic for LACV [6,16].  Case data for probable and confirmed 
cases of LACV infections from 1997-2006 were provided by the East Tennessee 
Regional Health Department, upon written release by patients infected with LACV.  
Variables used in this study were: patient residence, patient age, and infection onset date. 
Personal identifiers of patients were deleted before the database was released to 
investigators.  Location data was available for 15 probable and 76 confirmed cases of 
LACV infections reported during this time period.  Probable and confirmed cases (n = 
91) were combined for all analyses. 
Confirmed cases of LACV infections met both the clinical and laboratory 
requirements set by the Centers for Disease Controls and Prevention‟s case definition for 
neuroinvasive domestic arboviral diseases [132,153].  Cases that met the clinical 
definition and the initial antibody screening that detected virus specific antibodies, were 
classified as probable cases. 
Population and geographic data.  The majority of LACV infections are 
pediatric [4,5,29,118], therefore it is not appropriate to use the total population as the 
denominator when calculating risk.  The use of 0-18 and 0-15 year old population cohorts 
would be more appropriate for the calculation of risk for these infections.  Thus, the 2000 
United States Census was used to calculate the total population, the 0-18 and the 0-15 
year old cohorts for each county and census tract.  These populations were used to 
provide the denominators for the calculation of incidence risk at both the county and 





Figure 3. Maps of the study area. 






Geographic boundary files were downloaded from the United States Census, TIGER, 
Geodatabase [156], and used for all cartographic displays. 
Statistical and geographic analyses.  The incidence risks were calculated at both 
the county and the census tract spatial scales and spatial analyses performed on 91 cases 
(100 percent) of all ages, 86 cases (94.5 percent) that were 0-18 years old, and 84 cases 
(92.3 percent) that were 0-15 years old, for which location data were available.  The 
incidence risks were calculated for all counties in the study area (n = 18), and for counties 
reporting cases of LACV infections for all three age groups (n = 14).  Incidence risks 
were also computed for all census tracts in the study area (n = 230), only those reporting 
cases (n = 55), census tracts reporting cases 0-18 years old (n = 52), and census tracts 
reporting cases 0-15 years old (n = 51).  Incidence risk was expressed as the number of 
cases per 100,000 persons. 
Descriptive analyses and the calculation of incidence risk were performed using 
STATA 10.0 [157].  To adjust for the high variances resulting from the small number of 
cases reported in some census tracts we smoothed the risk in the study area using spatial 
empirical Bayesian (SEB) smoothing [158,159,160,161], implemented in GeoDa [164], 
using inverse distance spatial weights.  This method allowed for the better visualization 
of spatial patterns compared to the maps of unsmoothed incidence risks at the census tract 
level. 
Evidence of spatial clustering was assessed by the Global Moran‟s I [162] and the 
Moran Local Indicators of Spatial Association (LISA) [163], implemented in GeoDa 




tested using 9999 permutations.  Cartographic displays were made using ArcView GIS 
9.2 [165]. 
Results 
Incidence risk.  Incidence risk varied by the geographic scales and population 
cohort (Table 3, 4).  Higher incidence risks were most evident at the census tract level 
and in the younger age cohorts (15 years and younger).  The incidence risk in the whole 
population, among counties reporting cases ranged from 0.94 to 46.88 per 100,000 
persons (median 8.77), whereas it was 11.86 to 133.33 per 100,000 persons (median 
27.72) among census tracts reporting cases (Table 3, 4).  In children 0-18 years old, the 
county-level incidence risk in those counties reporting cases, ranged from 3.91 to 188.37 
per 100,000 persons (median 34.93), while it was 44.27 to 547.05 per 100,000 persons 
(median 114.64) among census tracts reporting cases (Table 3, 4).  Among children 0-15 
years old, the county-level incidence risk in counties reporting cases ranged from 4.67 to 
226.35 per 100,000 persons (median 41.49), whereas the incidence risk in those census 
tracts reporting cases ranged from 50.89 to 673.85 per 100,000 persons (median 126.74) 
(Table 4, 5). 
Geographically, the highest risks were observed in the western and northeastern 
counties (Figure 4, 5).  However, assessment of the spatial patterns at the census tract 
level using SEB smoothed rates indicates that within the high risk counties presented in 
Figure 4, only a few census tracts had a high risk of LACV infections (Figure 5).  Thus, 
most of the census tracts in these seemingly high risk counties actually have a low risk of 




Figure 4. The unsmoothed incidence risk at the county level. 
These maps represent the distribution of unsmoothed risk of La Crosse infections at the county level for 
eastern Tennessee using three different populations to calculate incidence risk: a) total population, b) 






Figure 5. The unsmoothed and smoothed incidence risk at the census tract level. 
The maps in the left hand column represent the distribution of unsmoothed risk of La Crosse infections at 
the census tract level for eastern Tennessee.  The maps in the right hand column represent the distribution 
of spatial empirical Bayesian smoothed risk for La Crosse infections in the eastern Tennessee at the census 
tract level.  Incidence risk was calculated using three different population sets: a) total population, b) 
population 18 years and younger, c) population 15 years and younger.
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Table 3. Comparisons of the Incidence Risk of La Crosse Infections for Three at Risk Populations at the 
County Level in eastern Tennessee, 1996-2006 
 
  Incidence Risk per 100,000 persons 
At Risk Population  Obs. Median Range Mean Variance 
      
Total population  
(All Counties) 
18 7.60 0 – 46.88 9.65 129.47 
Total population  
(Only Those Counties Reporting Cases) 
14 8.77 0.94 – 46.88 12.40 132.50 
      
0-18 year old population cohort 
(All counties) 
18 26.26 0 – 188.38 38.17 2166.79 
0-18 year old population cohort 
 (Only Those Counties Reporting Cases) 
14 34.93 3.91 – 188.37 49.07 2257.14 
      
0-15 year old population cohort 
(All counties) 
18 31.43 0 – 226.35 44.79 3097.14 
0-15 year old population cohort 
 (Only Those Counties Reporting Cases) 
14 41.49 4.67 – 226.35 57.59 3256.33 
      
Obs. = Observations, and refer to the number of counties for the specific analysis 
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Table 4. Table  Comparisons of the Incidence Risk of La Crosse Infections for Three at Risk Populations at 
the Census Tract Level in eastern Tennessee, 1997-2006 
 
Obs. = Observations, and refer to the number of census tracts for the specific analysis
  Incidence Risk per 100,000 persons 
At Risk Population Obs. Median Range Mean Variance 
      
Total population  
(All Census Tracts) 
230 0 0 – 133.33 8.13 339.59 
Total population  
(Only Those Census Tracts Reporting Cases) 
55 27.72 11.86 – 133.33 33.99 544.87 
      
0-18 year old population cohort 
(All Census Tracts) 
230 0 0 – 547.05 33.82 6242.02 
0-18 year old population cohort 
 (Only Those Census Tracts Reporting Cases) 
52 114.64 44.27 – 547.046 149.57 10374.16 
      
0-15 year old population cohort 
(All Census Tracts) 
230 0 0 – 673.85 37.45 8088.70 
0-15 year old population cohort 
(Only Those Census Tracts Reporting Cases) 
51 126.74 50.89 – 673.85 168.90 14401.27 
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risk are clustered in a few census tracts in the western and northeastern parts of the study 
area.  This pattern seems to persist across all three age groups studied. 
Geographic hot-spots of infection.  Spatial analyses using the Global Morans I 
and the LISA were first performed at the county level, using all three at-risk population 
cohorts.  No significant (p > 0.05) spatial clustering was demonstrated using the global 
statistic for the county level analysis using all at-risk population cohorts.  However, the 
LISA analysis revealed, significant clusters (p < 0.05) using both the total at risk 
population and 0-18 year old cohort, with each reporting the same cluster in Union 
County.  No significant high risk clusters (p > 0.05) were detected using the 0-15 year old 
population cohort.  At the census tract level, the global Morans I value was 0.1753 (p = 
0.0004), 0.1801 (p = 0.0008), and 0.1863 (p = 0.0007) using the total at risk population, 
0-18 and 0-15 year old age cohorts, respectively.  Twelve census tracts in the study area 
displayed evidence of significant clustering of high incidence risk (p < 0.05) detected by 
LISA, for all the three at risk population cohorts (Figure 6).  Four types of spatial 
autocorrelation are observed using the LISA statistic (High-High, Low-Low, High-Low, 
and Low-High).  Positive spatial autocorrelation are represented by High-High and Low-
Low, and negative spatial correlation by High-Low and Low-High.  Positive spatial 
autocorrelation (i.e. an association of areas of similar values) were represented as either 
High-High (i.e. a high risk in an area surrounded by similarly high values in neighboring 
areas) or Low-Low (i.e. a low risk in an area surrounded by similarly low values in 
neighboring areas).  Negative spatial autocorrelation (i.e. an association of areas of 
dissimilar values) was represented as either High-Low (i.e. a high rate in an area 






Figure 6. The spatial clustering of La Crosse virus infections at the county and census tract levels. 
These maps show the significant clustering of La Crosse infections at the county level for the total 
population and the 0-18 year old cohort (a) and at the census tract level for all three population cohorts (b) 




surrounded by high values in neighboring areas).  Significant high risk clusters were 
detected in Claiborne County (4 census tracts) and in Cumberland County (8 census 
tracts).  The incidence risk in the 12 census tracts displaying evidence of significant high 
risk spatial clustering ranged from 67.98 to 673.85 (median 177.62) per 100,000 persons 
for the 0-15 year old population cohort, with the other at-risk populations displaying a 
similar high incidence risk (Table 5). 
Discussion 
In this paper, we have presented evidence of the variation that can occur when 
using different at-risk population cohorts and geographic scales to determine the 
incidence risk and to investigate evidence of clustering.  Traditionally, incidence risk has 
been reported at the county level by public health officials, though with focal diseases, 
this large geographic scale may mask the underlying disease patterns at lower geographic 
scales.  Even so, our findings of a mean incidence risk of 57.59 per 100,000 persons was 
much higher than those reported by studies in West Virginia, Wisconsin, and Minnesota 
for the 0-15 year olds, where the incidence risk ranged from 20 to 31 per 100,000 persons 
at the county level [10,15].  The reason for this higher mean incidence risk is unclear, but 
could be a result of increased risk of disease transmission, higher rates of diagnosis due to 
increased awareness of the disease as well as higher and better rates of reporting.  This 
also raises concerns about the problem of under-diagnosis and/or underreporting of 
severe LACV cases to the health surveillance system. 
As expected the higher incidence risks were observed in the younger at-risk age 
cohorts.  Moreover, the differences in incidence risks between the county and the census 
tract spatial scales were startling.  The highest incidence risk in the 0-15 age cohort at the
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Table 5. At Risk Populations, Significant Clusters, and the Measures of Incidence Risk at the Census Tract Level for those Census Tracts Displaying 
Evidence of Spatial Clustering. 
  Incidence Risk per 100,000 persons 
At Risk Population Significant High Clusters* Median Range Mean Variance 
      
Total population 12 33.20 15.22 – 133.33 46.27 1344.76 
      
0-18 year old population cohort 12 157.48 59.35 – 547.05 204.79 20895.40 
      
0-15 year old population cohort 
 
12 
177.62 67.98 – 673.85 235.22 30889.71 




county level was 226.35 per 100,000 persons and was as high as 673.85 per 100,000 
persons at the census tract level.  When the incidence risk was calculated for only those 
census tracts within the significant clusters the median incidence risk changed from 
126.74 cases per 100,000 persons to 177.62 per 100,000 persons.  This information is 
very useful for public health efforts to control disease as it provides health professionals 
with precise information regarding the geographic locations and age cohorts to target 
control strategies and limited resources. 
These findings highlight the focal nature of this virus at levels lower than the 
county level.  Although most health reports have always reported health outcomes at the 
county level, the results from our study indicate that the census tract may be a better level 
for reporting results as it would provide more precise information regarding high risk 
populations.  Additionally, our findings seem to suggest that there has been a significant 
increase in disease risk and to our knowledge the highest incidence risk as of yet reported 
in the literature. 
When combined with maps of incidence risk, the use of spatial statistics allows 
public health professionals to target their limited resources for disease control to active 
hot-spots of infection (disease).  The results from our cluster analyses showed only one 
significantly high cluster of risk at the county level using the total at risk population and 
the 0-18 year old population cohort, while no significantly high risk clusters were 
detected using the 0-15 year old population cohort.  This finding highlights the variability 
that the at-risk populations can have on the spatial analyses, and the need for choosing the 
appropriate at-risk population and geographic scale for analyses. 
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At the census tract level, all the at-risk populations had statistically significant 
geographic hot-spots which occurred in two counties.  Though these analyses detected 
clusters using all population cohorts at the census tract level it should be cautioned that in 
other regions only the analysis including 0-18 and 0-15 year old age cohorts detected 
evidence of spatial clustering at the census tract level, highlighting the variability of risk 
when different age cohorts are studied.  Ultimately, the use a lower geographic level 
allows for the detection of clusters that would be missed at higher levels.  These results 
underscore the need to perform spatial analysis at the lowest possible level to ensure that 
the underlying spatial disease pattern is not missed. 
There are some limitations associated with this data and the methodology used in 
this study.  The probable and confirmed cases were reported through a passive 
surveillance system.  These systems are prone to under-reporting as only the most severe 
cases typically present for treatment.  Not withstanding this limitation we feel that these 
cases form the general picture of disease reporting in this region.  A downside to the use 
of the LISA in spatial analyses is the issue of multiple comparisons, which in turn 
increase type I error rates.  These were not adjusted for because such adjustments for type 
I errors would result in increases in type II errors [159,169].  Thus, such adjustments 
would in turn lead to a reduction in our test‟s power to detect truly significant clusters as 
observed by Rothman and others [169]. 
Identified patterns in the geographic distribution of disease incidence is useful 
both to help target areas and populations for intervention purposes and for the allocation 
of funding for research of disease control.  In the United States, Public Health Agencies 
typically report the incidence at the county level.  This is true for many arthropod-borne 
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viruses (arboviruses) and other diseases reported to the Centers for Disease Control and 
Prevention [153].  However, our findings indicate that the calculation and reporting of 
incidence risk at these larger geographic levels (ie county) may lead to a distortion of the 
underlying spatial patterns of disease risk.  This would be most apparent in focal diseases 
involving a small number of cases and affecting only a sub-set of the general population. 
Our findings both reaffirm and highlight the need for the use of the appropriate at-
risk population and geographic levels of analysis and reporting of incidence risk 
involving focal diseases affecting only a sub-set of the population.  The 0-15 year old 
population cohort would provide a more realistic representation of true risk for this virus, 
when reported at the census tract level.  We believe that the continued use of the most 
appropriate geographic level of geography and at-risk population for LACV infections 
and other diseases will allow public health officials to better target limited resources for 






The spatial epidemiology, clinical presentation, and environmental factors influencing 
the transmission of La Crosse virus infections in West Virginia, 2003-2007. 
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The spatial epidemiology, clinical presentation, and environmental risk factors 








The objective of this study was to investigate and describe the spatial 
epidemiology, clinical presentation, and environmental risk factors associated with La 
Crosse virus (LACV) infections reported in West Virginia.  Descriptive and cluster 
analyses were performed on probable and confirmed LACV infection cases reported to 
the West Virginia Department of Health and Humans Resources from 2003 to 2007.  
Significant (p < 0.05) high risk clusters were detected at both the county (n = 4) and at 
the census tract (n = 30) levels by global and local spatial statistics.  The county level 
incidence risk for those counties in high risk clusters ranged from between 40.21 to 
166.82 cases per 100,000 persons (median 83.16), and between 61.73 to 505.91 cases per 
100,000 persons (median 156.50) for those census tracts located in high risk clusters.  
Cases ranged in age from 0.42 to 54 years, with a majority (84 percent) occurring in 
children 15 years and younger.  Most cases presented during July (28 percent), August 
(38 percent), and September (17 percent), in the southern region of the state.  The most 
commonly reported symptoms were fever, vomiting, photophobia, and nausea.  Clinically 
reported infections presented as meningitis (41 percent) and encephalitis (40 percent).  A 
case fatality rate was reported in 3 percent of patients.  The most commonly observed 
environmental variables at case residences were the presence of a wooded area (91 
percent) and the presence of containers (70 percent).  The presence of standing water was 
observed at almost half of the cases sites (49 percent), and the majority of case sites (76 
percent) were located within 45.6 m (149 ft) of a wooded area.  Our findings of a higher 
than expected case-fatality rate and the identification of those areas of highest risk will be 




La Crosse virus (LACV) is a member of the genus Orthobunyavirus family 
Bunyaviridae, and is the causative agent of LACV infections.  LACV was first isolated 
from the brain of a deceased pediatric patient who died of encephalitis in 1964 [1], and is 
one of the most common causes of pediatric arboviral encephalitis in the United States 
[2,3].  It is transmitted to humans through the bite of infective mosquitoes, the primary 
vector being the eastern tree-hole mosquito, Aedes triseriatus [20].  The virus is 
maintained in a complex cycle involving both horizontal and vertical transmission in 
mosquitoes and as well as amplification in squirid hosts [21,22,27,28] and is typically 
associated with areas of dense vegetation and/or stands of hardwood trees [11,16,116].  
The traditional focus of viral transmission has been in the upper-midwestern United 
States [2,4,5], but more recently LACV infections have been seen as an emerging disease 
in West Virginia [8,9].  The majority of cases occur in children under 15 years of age 
[4,5,29,118], with an average of 100 nationally reported cases per year, though some 
estimates range much higher [13].  The true incidence of LACV infections are unknown 
as they are under diagnosed and underreported [6].  
From 1964 to 1986, there were 15 reported cases of LACV infections in West 
Virginia, or 0.87 percent of nationally reported cases.  An outbreak LACV infections at a 
pediatric referral center in 1987 led to active surveillance for LACV in 15 counties, in 
turn leading to the detection of 19 cases of LACV infections [10].  Eleven of the patients 
had encephalitis, 4 with meningitis, and 4 had meningo-encephalitis.  The ages of patients 
ranged from 1 to 14 years of age and all fell within the traditional age range of confirmed 
cases [2,5,42].  Males were found to be more likely infected than females, the ratio being 
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3.8:1 respectively.  Ninety-five percent of the patients were hospitalized and one died.  
This marked a substantial increase in LACV infections in the state and led to increased 
surveillance and research activities.  From 1987 to 2007, West Virginia reported 555 
cases of LAC encephalitis to the CDC, accounting for 31.4 percent of the total cases 
reported in the United States (Centers for Disease Control, unpublished data).   
Following this initial outbreak a case-control study was undertaken to determine 
the effects of tree holes, artificial containers, and environmental and behavioral factors 
influencing the transmission of LACV in West Virginia [30].  Cases were matched by 
age, sex, and geographic location with two controls. A slight increase in disease risk (OR 
< 2.0) was found for an increased time spent outdoors, the non-use of insect repellant, the 
non-use of air conditioning, a lack of screened windows, and the non-use of protective 
clothing.  The presence of tree holes near a residence was found to significantly increase 
the risk of transmission (OR = 8.5 for  1 tree hole vs. 0 tree holes).  Factors found to not 
statistically significantly increase the risk of disease transmission were artificial 
containers (OR = 4.1 for  6 containers vs. 0 – 5 containers), discarded tires (OR = 3.2 
for  10 tires vs. 0 – 9 tires), and the proximity to forest edge (OR = 3.2 for 0 – 14.9 m 
vs.  14.9 m).  The authors concluded that though these factors were not statistically 
significant they could still result in increased disease transmission not detected due to 
limitations of the study. 
We conducted both a spatial and descriptive analyses of LACV infections 
reported in West Virginia from 2003-2007 in an effort to determine those areas at the 
highest risk for infections, assess the clinical presentation of infections, and to determine 
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the environmental risk factors of case sites, in an effort to guide intervention strategies by 
public health officials. 
Methodology 
Case data.  Probable and confirmed cases of LACV infections were collected 
through passive surveillance from 2003 to 2007, and were obtained from the West 
Virginia Department of Health and Human Resources.  Personal identifiers of patients 
were deleted before the data were released for the study.  Clinical data were available for 
96 cases, and data on the location of residence were available for 68 patients.  Ages 
ranged from 0 to 15 years old. 
Confirmed cases of LACV infections met both the clinical and laboratory 
requirements set by the Centers for Disease Control and Prevention‟s case definition for 
neuroinvasive domestic arboviral diseases [132,153].  Those cases that met the clinical 
definition and the initial antibody screening detecting virus specific antibodies, were 
classified as probable cases. 
Population, geographic, and environmental data.  As the majority of LACV 
infections are pediatric [4,5,29,118], it was deemed appropriate to use the 0-15 year old 
population for the calculation of incidence risk for these infections.  The decennial 2000 
United States Census was used to calculate the 0 to 15 year old population for each 
county and census tract.  Geographic boundary files were downloaded from the United 
States Census, TIGER, Geodatabase [156], and used for all cartographic displays. 
Environmental officers of the West Virginia Department of Health and Human Resources 
conducted environmental assessments at both probable and confirmed patients residences 
during the study period. 
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Statistical and geographic analyses.  The incidence risks were calculated at both 
the county and the census tract spatial scales and spatial analyses was performed on 68 
cases 0 to 15 years old for which location data were available.  The incidence risks were 
calculated for all counties in the study area (n = 55), for counties reporting cases (n = 18), 
and for all census tracts in the study area (n = 466), and for census tracts reporting cases 
(n = 50).  Incidence risk was expressed as the number of cases per 100,000 persons. 
Descriptive analyses and the calculation of incidence risk were performed using 
STATA 10.0 [157].   We adjusted for the high variances resulting from a small number of 
cases reported in some counties and census tracts by smoothing the risk using spatial 
empirical Bayesian (SEB) smoothing [158,159,160,161].  This technique was 
implemented in GeoDa [164] using inverse distance spatial weights.  The use of SEB 
smoothing increased the overall visual perception of spatial patterns when compared with 
unsmoothed maps of incidence risks. 
Evidence of spatial clustering was assessed by the Global Moran‟s I [162] and the 
Moran Local Indicators of Spatial Association (LISA) [163], implemented in GeoDa 
Version 0.95i [164], using inverse distance spatial weights.  Statistical significance was 
tested using 9999 permutations.  Cartographic displays were made using ArcView GIS 
9.2 [165]. 
Results 
Spatial analyses.  The highest incidence risks were observed at the census tract 






Table 6. Comparisons of the Incidence Risk of La Crosse Infections for West Virginia County and Census 
Tracts 
 
                                                                         Incidence Risk per 100,000 persons 
Geographic Risk Level Obs. Median Range Mean Variance 
      
County 
(Entire Study Area) 
55 0 0-166.82 15.48 1057.69 
County 
(Only Those Reporting Cases) 
18 32.07 7.20-166.82 47.29 1766.50 
County 
(Only those in High-Risk Clusters) 
4 83.16 40.21-166.82 93.35 2871.96 
      
Census tract 
(Entire Study Area) 
466 0 0-505.90 17.39 3158.20 
Census tract 
(Only Those Reporting Cases) 
50 150.04 42.41-505.90 162.08 6042.14 
Census tract 
(Only those in High-Risk Clusters) 
30 156.50 61.73-505.91 180.66 7604.50 
 
Obs = Observations, and refer to the number of counties or census tracts used for each analysis. 
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166.82 per 100,000 persons (median 32.07), and from 42.41 to 505.90 per 100,000 
persons for those census tracts reporting cases. 
 The highest unsmoothed risks were observed in the south-central region of the 
state at both the county and census tract levels (Figure 7).  Visually, the spatial patterns of 
SEB smoothed risk at the county and census tract levels were more evident and followed 
similar patterns as the unsmoothed risks (Figure 7), though only some of the census tracts 
within the high-risks counties, had high-risks of infection. 
The Global Morans I detected significant clustering at the county and census 
tracts with values of 0.4986 (p = 0.0001) and 0.2935 (p = 0.0001), respectively.  The 
LISA detected significant (p < 0.05) high risk clusters at both the county (n = 4) and at 
the census tract (n = 30) levels (Figure 8).  At the county level significant high risk 
clusters were detected in Fayette, Raleigh, Nicholas, and Wyoming counties.  Significant 
high-risk clusters were detected at the census tract level within the counties of Fayette (9 
census tracts), Mercer (9 census tracts), Raleigh (8 census tracts), Nicholas (2 census 
tracts), Kanawha (1 census tract), and Wyoming (1 census tract).  The county level 
incidence risk for those counties in high risk clusters ranged from between 40.21 to 
166.82 cases per 100,000 persons (median 83.2), and between 61.73 to 505.91 cases per 
100,000 persons (median 156.5) for those census tracts in high risk clusters (Table 6). 
Clinical.  Cases ranged in age from 0.42 to 54 years, with a mean age of 10.8 (SD 10.3) 
years, of which 84 percent occurred in children under the age of 15 (Table 7).  The vast 
majority of cases presented during July (28 percent), August (38 percent), and September 





Figure 7. The unsmoothed and smoothed incidence risk at the county and census tract level. 
The distribution of unsmoothed risk of La Crosse infections at the county (a) and the census tract level (c) 
for West Virginia.  The distribution of spatial empirical Bayesian smoothed risk for La Crosse infections in 




Figure 8. The spatial clustering of La Crosse virus infections at the county and census tract levels. 
These maps show the significant high clustering (HIGH-HIGH) of La Crosse infections at the county level 




Table 7. Characteristics of Cases of La Crosse 
Infections Reported to the West Virginia 
Department of Health and Human Resources, 2003-
2007 
  
Variable Number (%) 
  
Sex  
     Male 58 (60) 
     Female 38 (39) 
  
Age  
     0.1 - 0.9 yr 1 (1) 
     1 - 5 yr 27 (28) 
     6 - 10 yr 38 (40) 
     11 - 15 yr 15 (16) 
     16 - 20 yr 6 (6) 
     ≥ 21 yr 9 (9) 
  
Month of presentation  
     May 1 (1) 
     June 8 (8) 
     July 27 (28) 
    August 36 (38) 
    September 16 (17) 
    October 8 (8) 
  
Reported Symptoms  
     Fever 73 (76) 
     Vomiting 72 (75) 
     Elevated CFS WBC 68 (71) 
     Photophobia 50 (52) 
     Nausea 48 (50) 
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Table 7 Continued. Characteristics of Cases of La Crosse Infections Reported to the West Virginia Department of Health and Human Resources, 
2003 to 2007 
 
      Weakness 40 (42) 
     Meningitis 39 (41) 
     Encephalitis 38 (40) 
     Stiff Neck 32 (33) 
     Confusion 32 (33) 
     Seizures 23 (24) 
     Elevated CSF protein 24 (25) 
     Myalgia 11 (11) 
     Rash 7 (7) 
     Arthralgia 7 (7) 
     Coma 4 (4) 
  
Died  
     Male 2 (2) 




The most common symptoms reported were fever, vomiting, photophobia, and nausea 
(Table 7).  Meningitis and encephalitis were reported in 41 and 40 percent of cases 
respectively. Other reported symptoms were weakness (42 percent), stiff neck and 
confusion (33 percent), seizures (24 percent), and coma (4 percent).  A case fatality rate 
was reported in 3 percent of patients.   
Elevated levels of white blood cell (WBC) counts in cerebral spinal fluid (CSF) 
were reported in 73 cases (76 percent), of which 68 cases had counts ranging from 10 to 
670 per mm
3
, with a mean count of 160.9 per mm
3
 (SD 153.8).  Health care providers 
reported either CSF protein levels and/or the presence of elevated CSF protein levels.  
CSF protein levels were available for only 27 cases, and ranged from 24 to 359 mg/dl, 
with a mean level of 64.4 mg/dl (SD 61.6).  Elevated CSF protein levels were reported in 
24 cases (25 percent).  Fever was present in all cases for which temperature was reported 
(n = 54), with a mean value of 39.4˚C (SD 0.66) and ranged from 38.3˚C to 40.6˚C 
(100.9˚F to 105˚F). 
Environmental.  The most commonly observed environmental variables at case 
residences were the presence of a wooded area (91 percent) and the presence of 
containers (70 percent) (Table 8).  The presence of standing water was observed at almost 
half of the cases residences (49 percent), and the majority of cases residences (76 
percent) were within 45.6 m (149 ft) of a wooded area (Table 9). 
Discussion 
The highest incidence risks were observed in the south-central region of the state, 




Table 8. The Observed and Reported Presence of Environmental 
Risk Factors at 97 Cases of La Crosse Infections Reported to the 
West Virginia Department of Health and Human Resources, 
2003-2007 
   
     Variable Present (%) Missing Data 
   
Containers* 60 (70) 11 
     Other containers
†
 53 (62) 12 
     Tires 33 (37) 15 
     Tarps 32 (41) 19 
   
Standing water 41 (49) 13 
   
Wooded area 81 (91) 8 
     Hardwood 68 (93) 24 
     Evergreen 35 (70) 47 
   
*Containers, were all containers including: other containers, tires, and tarps.  These variables were cross-





Table 9. The Numbers of Observed and Reported Potential Larval 
Habitats Present at 97 Cases of La Crosse Infections Reported to 
the West Virginia Department of Health and Human Resources, 
2003-2007 
   
     Variable Number (%) Missing Data 
   
No. of tires  20 
     0 49 (64)  
     1-9 21 (27)  
     ≥ 10 7 (9)  
   
No. of tarps  31 
     0 46 (70)  
     1-10 21 (32)  
   
No. of other types of    





     0 19 (26)  
     1-5 29 (39)  
     6-15 10 (14)  
     ≥ 16 3 (4)  
   
Distance (meters) from   
     residence to wooded    
     area 
 
23 
     0-14.9    (0-49 ft) 35 (57)  
     15-45.6  (50-149 ft) 21 (34)  
     ≥ 45.7    (≥ 150 ft) 6 (10)  
   
†




understood, but could be due to a variety of factors including increased surveillance, 
diagnosis, and reporting of infections. 
As anticipated, the highest incidence risks were observed at the census tract level 
rather than the county level (Table 7).  Our results further demonstrate that the census 
tract level would be the preferred geographic level for reporting cases and calculating 
incidence risk for focal diseases (Haddow in Review).  Further, we recommend reporting 
the range of incidence risk rather than only the mean incidence risk within those census 
tracts reporting cases.  Such reporting would provide a more representative picture of the 
burden of disease risk. 
Significant high disease clustering was observed at both the county and census 
tract levels and was detected in the south-central region of the state.  Four clusters of 
disease were detected at the county level, while there were 30 clusters observed at the 
census tract level, which were located within 6 counties.  These results demonstrate the 
usefulness of using the lower geographic levels and spatial statistics for the detection of 
disease clusters of focal diseases. 
A 2003 study reported the occurrence of mosquito larvae inhabiting tires in 
different geographic regions (western, central, and eastern) of the state [19] and provides 
the most recent account of the biology and distribution of vector species in West 
Virginia.  The results of this study inferred a shift in vector abundance in West Virginia, 
with Ae. japonicus being collected more frequently than Ae. triseriatus in all geographic 
regions of West Virginia, thus increasing the likelihood that this species could be an 
accessory vector of LACV in West Virginia.  Further findings that Ae. albopictus were 
collected at significantly lower (p < 0.05) numbers than Ae. triseriatus at both 
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peridomestic and non-peridomestic sites in the central and eastern regions of the state 
could indicate that Ae. albopictus is not playing an important role as accessory vector of 
LACV in West Virginia [9,10,30], as these regions experienced the highest incidence 
risks and were also the areas of the significantly high disease clusters. 
In agreement with previous work [29], our study shows that the majority of 
reported LACV infections occur in male children 15 years and younger during the 
summer months and display fever, headache, vomiting, and mental status changes.  These 
cases have traditionally proven difficult to distinguish from Herpes simplex 
meningoencephalitis [29,138].  The elevated CSF WBC counts found in our study remain 
a diagnostic tool, though the results should be interpreted with caution as patients 
frequently demonstrate a predominance of Polymorphonuclear Leukocytes on their 
peripheral blood smear and CSF [29].  Such findings may suggest a bacterial infection, 
and may result in a possible delay in the diagnosis of this viral illness [29].  A troubling 
discovery in this study is the continued high case fatality rate (3 percent) in West Virginia 
[30], compared to a much lower case fatality rate (1.5 percent) reported during the same 
time period for the rest of the United States [30,153].  The reason for this higher case 
fatality rate in West Virginia is unclear, but may indicate the possibility of a more 
virulent strain(s) of the virus circulating in this region [67]. 
 The presence of a wooded area with tree-holes and containers are widely 
acknowledged as risk factors for LACV [2,4,14,30,148,151].  We found that a majority 
of cases, 76 percent, were within 45.6 m (149 ft) of a wooded area, and 70 percent had 
observed containers present at case residences.  The presence of water holding containers 
remains a high source of larval habitat at these sites, and of these cases, 37 percent had 
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observed tires, 37 percent had observed tarps, and 62 percent had the observed presence 
of other types of containers.  
Though we had no control group to compare our findings, the large number of 
cases with the observed proximity to wooded areas and containers near the case 
residences are in agreement with the findings from a previous study in this region as a 
risk factor for LACV [30].  Thus, the elimination of water holding containers and the 
closure of tree-holes would likely reduce the overall burden of infective mosquitoes and 
decrease the risk of LACV transmission, as seen elsewhere [148].  
Due to the methodology and data employed in our study there are some 
limitations. Passive surveillance systems are prone to under-reporting/detection of 
disease, though we feel that the majority of cases suffering from severe illness were 
diagnosed and reported to state health officials.  Clinical data was reported from multiple 
health care providers to the West Virginia Department of Health and Human Resources, 
which did not allow for the verification of laboratory results and the diagnosis of the 
specific clinical presentation for each patient.  Another drawback is the issue of multiple 
comparisons, which can occur when using the LISA statistic for cluster detection, which 
would increase type I errors.  These errors were not adjusted for, as adjustments for type I 
errors would increase type II errors [159,169], in turn reducing the ability to detect truly 
significant clusters [169]. 
During the study period, West Virginia reported the highest incidence risk of 
LACV infections in the United States, marking a shift from the traditional focus of 
transmission from the upper Midwestern States to the Appalachian Region.  The reason 
for this shift is unclear, but could be due to a variety of factors including increases and/or 
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decreases in diagnosis, reporting and prevention.  Future case-control studies are needed 
to determine current risk factors and should include vector and host sampling.  In 
addition virus isolations are needed to compare WV virus strains with virus strains from 
other regions. Though reporting of the clinical presentation of LACV infections through a 
passive surveillance system is not without limitations, such reporting will allow for the 
continued monitoring of trends in the virulence of infections.  Our findings demonstrate 
that south-central West Virginia remains a focus of LACV transmission and highlights 
the utility of using the combination of incidence risk and spatial statistics to detect areas 
of high virus transmission.  The presence of wooded areas and containers in virus foci 
remain a risk factor for acquiring LACV.  These findings will allow public health 
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In the last ten years there has been a significant increase in the number of reported 
cases of La Crosse virus (LACV) infections in eastern Tennessee. The objective of this 
study was to determine the abundance and habitat preferences of the potential vectors of 
LACV in this region.  Adult host-seeking mosquitoes were collected using CO2-baited 
Centers for Disease Control (CDC) light traps and by a series of human-landing catches 
in eastern Tennessee from 2004 to 2006.  A total of 23 species, totaling 4,200 female 
mosquitoes were collected by CO2-baited CDC trapping at 10 sites during the study 
period.  Aedes albopictus (Skuse) was the most abundant mosquito collected at all sites 
and vegetation types, with the ratios of total Ae. albopictus to Ae. triseriatus (Say) 
females collected being 2.1:1 in 2004, 3.8:1 in 2005, and 4.9:1 in 2007.  Ten species of 
mosquitoes were collected during a series of human-landing catches made at four 
different sites; one probable and three confirmed case sites of LACV infections, totaling 
528 female mosquitoes.  Aedes albopictus was the most abundant species collected, with 
the proportion of Ae. albopictus to Ae. triseriatus females collected being 4:1.  Aedes 
albopictus exhibited two clear peaks of “landing” activity, one in the early morning and 
one in the late afternoon or early evening.  Simple and multiple regression analyses of the 
predictors of the number of mosquitoes collected, showed that populations of Ae. 
albopictus were three times more likely to be collected overall than Ae. triseriatus.  
Species (Ae. albopictus), vegetation (residential), and the previous cumulative 
precipitation for the four weeks prior to collection were significantly (P < 0.05) 
associated with the number of mosquitoes collected by CO2-baited CDC trapping.  Aedes 
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albopictus was also more likely to be collected than Ae. triseriatus at confirmed cases of 
severe LACV infections. 
Introduction 
La Crosse virus (LACV) is one of most frequently identified arboviral causes of 
pediatric encephalitis in the United States [2,3].  It has traditionally been associated with 
the upper-Midwestern United States [4] though it has been reported in other regions [9]; 
recently as an emerging disease the southeastern United States [6,7,16].  LACV 
infections became seasonally epidemic in eastern Tennessee in the mid-1990‟s coinciding 
with the establishment of Aedes albopictus (Skuse) (Gerhardt unpublished).  Prior to the 
mid-1990‟s, there had been nine reported cases of LACV infections from 1964-1996 in 
Tennessee [6]. 
Aedes triseriatus (Say) is considered the primary vector of LACV within its 
traditional range [2,9,21].  It is typically associated with hardwood forests and is 
primarily a tree-hole mosquito, but will also oviposit in man-made containers [9].  LACV 
can be transmitted transovarially and venereally in this species and is able to overwinter 
in its eggs [4,21,22,26,85].  It is known to feed on a variety of mammals including 
squirrels, chipmunks, and humans [86].  This species is widely distributed throughout the 
eastern United States (Darsie & Ward 1981) and has been found at LACV infection case 
sites in Tennessee [16].  The invasive mosquito Ae. albopictus was first collected in the 
USA in Houston, Texas in 1985 [89] and is believed to have been introduced to the 
United States through shipments of tires from Asia [90,91].  Since its establishment, Ae. 
albopictus has spread over a large portion of the United States, including Tennessee 
[92,172].  It is known to feed on a variety of animals including man [93,114]; its larvae 
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are found in both man-made containers and tree holes [35,91].  Aedes albopictus has been 
shown to be a competent laboratory vector of several viruses, including LAC virus [23], 
and may be associated with the increase of LACV infections in Tennessee [16,17]. 
Continued surveillance recently detected the establishment of a second invasive 
mosquito vector capable of transmitting the virus, Ae. japonicus (Theobald) [24,38].  
Aedes japonicus has been found at case sites of LACV infections in the region, in 
addition to Ae. triseriatus and Ae. albopictus [16,17,20,35,36,99].   
In 1997, a cluster of 10 cases of LACV infections were detected in eastern 
Tennessee [6], during which time active surveillance for the virus was initiated by both 
the University of Tennessee and The Tennessee Department of Health.  Surveillance 
included mosquito trapping at LACV infection case sites [6,16,17,35].  Trapping of 
mosquitoes at these sites led to the first isolation of LACV from Ae. albopictus (TN00-
2266) and the first isolation of the virus in Tennessee.  This isolation came from a pool of 
14 reared females collected as eggs at a confirmed case site (onset date 23 June 1998) in 
Anderson County, 16 August 1999 [17].  The minimum infection rate for Ae. albopictus 
eggs oviposited at the site was determined to be 6.5/1000 for the isolation week, with a 
ratio of collected Ae. albopictus to Aedes triseriatus (Say) of 153:1.  This residence was 
well maintained with an oak and hickory forest located 15 meters from the residence.   
To determine the abundance and habitat preferences of the vectors of LACV in 
eastern Tennessee and to explore the role of Ae. albopictus as a potential vector of 
LACV, weekly seasonal trapping of host-seeking species was initiated in 2004 and 
continued through 2006.  In addition, a series of human-landing catches were conducted 




Study Areas.  Collections took place at 14 sites in four counties in eastern 
Tennessee (Table 10), an area endemic for LACV transmission [6,7,16].  Sites were 
classified as either probable sites of LACV infection, confirmed sites of LACV infection, 
or sites having no previously reported cases of LACV infections, by the Tennessee 
Department of Health.  CO2-baited CDC trapping took place at 10 sites in Knox County.  
Knox County has total area of 508.46 square miles and a population density of 752 
persons per square mile [173]. Human-landing catches also took place in: Campbell 
County, total area of 480.07 square miles, and a population density of 83 persons per 
square mile; Claiborne County, total area of 434.28 square miles, and a population 
density of 68.8 persons per square mile; and Union County, total area of 223.56 square 
miles, and a population density of 79.5 persons per square mile [173]. 
Vegetation. The predominant vegetation species were identified at each 
collection site for the canopy, intermediate, understory, and ground levels (Table 11).  
Vegetation types at each site were further characterized using the “The Forest Cover 
Types of the United States and Canada” [174], with the exception of residential and 
agricultural sites which did not meet the requirements for characterization and were 
defined by their location within residential or agricultural areas. Vegetation was then 
classed into four types: northern red-oak, yellow-poplar white-oak, residential, and 
agricultural (Table 10). 
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Table 10. Site identification, trapping years, vegetation type, county, catch type and the reporting of La Crosse infection from 2004 to 2006. 
 
 
     Site Identification 
Trapping 
Years 




      
1 All 
Yellow – poplar – white oak –
northern red oak 
Knox CO2-baited CDC trap Confirmed 
2 All Northern red oak Knox CO2-baited CDC trap No 
3 All 
Yellow – poplar – white oak –
northern red oak 
Knox CO2-baited CDC trap No 
4 2004 Urban – residential Knox CO2-baited CDC trap No 
5 All 
Yellow – poplar – white oak –
northern red oak 
Knox CO2-baited CDC trap No 
6 All Urban – residential Knox CO2-baited CDC trap No 
7 All 
White oak – black oak – northern red 
oak 
Knox CO2-baited CDC trap Confirmed 
8 All 
Yellow – poplar – white oak –
northern red oak 
Knox CO2-baited CDC trap Confirmed 
9 2005, 2006 Northern red oak Knox CO2-baited CDC trap No 
10 2005, 2006 Urban – residential Knox CO2-baited CDC trap No 
11 2004 
Yellow – poplar – white oak –
northern red oak 
Campbell Human landing-catch Confirmed 
12 2004 Agricultural Claiborne Human landing-catch Confirmed 
13 2004 
Yellow – poplar – white oak –
northern red oak 
Campbell Human landing-catch Confirmed 
14 2004 
Yellow – poplar – white oak –
northern red oak 
Union Human landing-catch Probable 
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Table 11. Stratification of vegetation by site. 
Vegetation Species Stratification of Vegetation Dominance 
 Canopy Intermediate Understory Ground 
Albizia julibrissin (mimosa)   4, 13  
A. saccharum (sugar maple) 4, 6, 7, 8 5, 6, 7, 8 
1, 2, 3, 6, 7, 
8, 12, 23, 14 
 
Carpinus caroliniana (American hornbeam)  3 7, 8  
Carya cordiformis (bitternut hickory) 1, 2, 7, 8, 10 7   
C. glabra (Pignut hickory) 2 2   
C. ovata (shagbark hickory) 9    
Celtis occidentalis (hackberry) 4, 9 9   
Cercis canadensis (eastern redbud)  8, 13 8  
Cornus florida (flowering dogwood)  1, 5, 14 7, 13  
Fagus grandifolia (American beech)   9, 11  
Hedera helix (English ivy)    5, 6 
Juniperus virginiana (eastern red cedar) 4, 6 3 10, 12  
Ligustrum sp. (privet)   
1, 3, 4, 5, 6, 
7, 9, 11, 14 
9, 11, 13 
Liriodendron tulipifera (yellow poplar) 1, 3, 5, 8, 
11, 13, 14 
5, 11, 13   
Liriope sp. (lily turf)    3, 10 
Loncicera tartarica (honeysuckle)  13 2, 3, 9, 11  
L. japonica (Japanese honeysuckle)   3, 4, 5, 6 
1, 2, 4, 5, 6, 
7, 10, 13 
Oxydendrum arboreum (sourwood)  1   





Table 11 Continued. Stratification of vegetation by site. 
 
Phyllostachys sp. (bamboo)  5 5  
Poa sp. (bluegrass)    
4, 5, 9, 10, 
11, 12, 14 
Prunus serotina (black cherry)  3, 4 , 10 8  
Quercus alba (white oak) 3, 7, 11, 13, 
14 
3, 5, 11, 13, 
14 
1, 6, 8, 11  
Q. falcata (southern red oak) 7, 10  1  
Q. prinus (chestnut oak) 2 8, 9 1, 14  
Q. rubra (red oak) 
2, 3, 5, 8, 9, 
10, 11, 12, 
14 
8 6, 9  
Ribes sp. (gooseberry)    
2, 3, 7, 8, 
11, 13 
Rosa sp. (rose)    2, 3 
Tilia americana (American basswood)  2, 5, 8 5  
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Sampling techniques.  Adult host-seeking mosquitoes were collected using CO2-
baited Centers for Disease Control (CDC) light traps (John W. Hock Company, 
Gainesville, FL) with the lights removed.  Trapping methodology has been described 
elsewhere [175], briefly each trap had ~ 2 kg of dry ice placed inside a modified Igloo  
cooler (John W. Hock Company, Gainesville, FL) suspended above the trap allowing for 
sublimation of the dry ice directly above the traps location.  Traps were suspended 
approximately 1.0 m off the ground, at the same location at each site for each trapping 
year.  Each site had one trap in operation for 24 H time period, once a week, from 
epidemiological week 23 through week 40 for each trapping year.  Adult mosquitoes 
were identified by species and sex [87].  
One human-landing catch took place at each of three confirmed and one probable 
case site of LACV transmission upon notification by the Tennessee Department of Health 
and release of confidentiality by the patient‟s guardians.  Cases were deemed to be 
confirmed if they met both the clinical and laboratory case definition set by the CDC, and 
cases were deemed to be probable upon the results of acute serum testing for IgM and 
IgG antibodies for LACV [132].  Catches were made seated by the same individual 
(A.D.H.), wearing the same clothes, in an effort to standardize any variables that might 
affect host attractiveness.  All collections took place from 30 minutes pre-civil twilight to 
30 minutes post-civil twilight during a one-day period.  Two different collection regimes 
were used.  At sites 11 (20 June 2004) and 12 (2 July 2004) each collection period lasted 
15 minutes.  Trapping took place at four locations each 20 meters apart around the 
perimeter of the residence, with each collection period taking place consecutively after 
the previous collection from the start until the conclusion of trapping.  At sites 13 (15 
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July 2004) and 14 (11 September 2004) a collection period lasted 30 minutes, and was 
made at two locations at each residence 20 meters apart.  Again each collection period 
took place consecutively following the previous collection period from the start until the 
conclusion of trapping.  Adult mosquitoes were collected in 15 mL Nunc EZFlip tubes 
(Nalge Nunc International, Rochester, NY).  Collected mosquitoes were stored at -20 C 
until taken to the laboratory where they were identified by species and sex [87]. 
Weather data.  Weather data was acquired from the National Climatic Data 
Center [176] for CDC trapping of adult host-seeking mosquitoes in Knox County, TN.  
The nearest weather station to Knox County, TN, having continuous data available for 
the study period was used (COOPID 4049950, 35 49N / 83 59W, elevation 293.2 meters 
above sea level).  COOPID 4049950 is located on the southern border of Knox County, 
TN and Blount County, TN.  All sites in Knox County were less than 40 km from 
COOPID 4049950.  Daily temperatures and precipitation were converted to weekly mean 
temperatures and cumulative weekly precipitation totals for the study period (Figure 9).  
Temperature and relative humidity for the period of each human-landing catch was 
collected at each site using a Kestrel 3000 Pocket Weather Meter (Nielsen Kellerman, 
Chester, PA).  Temperature and relative humidity readings were averaged to obtain mean 
readings for each two-hour period (Figure 10). 
Statistical analyses.  All statistical analyses were performed using STATA 10.0 
(STATA Corp. College Station, TX). Graphs were generated using DataGraph 10.5 Beta 
(Visual Data Tools, Inc., Chapel Hill, NC).  Simple regression analyses were used to 
assess the univariate associations between the numbers of adult female mosquitoes of a 











Figure 10. The mean temperature (top) and mean relative humidity (bottom) at a series of human-landing 
catches*. 
*Mean temperature and mean relative humidity were calculated from the three separate human-landing 
catches where Aedes albopictus and Aedes triseriatus were collected. 
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predictors: species, vegetation type, previous reporting of LACV infections, temperature 
for the week of collection (mean, min, max), precipitation for the week of collection, 
cumulative precipitation for the four weeks prior to each collection (Table 12). 
Variables that had significant univariate associations with the number of 
mosquitoes were further investigated using a multiple regression analysis.  These were: 
species (Ae. albopictus and Ae. triseriatus), vegetation type, cumulative precipitation for 
the four weeks prior to each collection.  Only variables that were significant (P < 0.05) in 
the multiple regression analyses were retained in the final model. 
Results 
Adult sampling.  During the three-year study period 23 species totaling 4,200 
female mosquitoes were collected using CO2-baited CDC traps (Table 13).   The three 
most frequently collected species during each of the three collection years were Ae. 
albopictus, Ae. triseriatus, and Ae. vexans (Meigen).  Aedes albopictus was the most 
abundant species collected during the study period, at all vegetation types, and all study 
sites.  Aedes triseriatus was the second most abundant species collected in 2004 and 
2006, and third most abundant in 2005.  Aedes vexans was the third most abundant 
species in 2004 and 2006, and the second most abundant species 2005.  The ratios of total 
Ae. albopictus to Ae. triseriatus females collected at all sites was 2.1:1 in 2004, 3.8:1 in 
2005, and 4.9:1 in 2007 (Figure 15). 
Ten species of mosquitoes were collected by human land-catches totaling 528 
female mosquitoes (Table 14).  Aedes albopictus was the most abundant species 
collected.  Aedes albopictus and Ae. triseriatus were collected from sites 11, 13, and 14.  




Figure 11. The total number of Aedes albopictus and Aedes triseriatus collected by CO2-baited CDC 
trapping for 2004 (top), 2005 (middle), and 2006 (bottom).
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Table 12. Variables used in the analysis to predict mosquito abundance. 
 





      
Number of 
mosquitoes 
Total number of 
mosquitoes collected 
Numeric Continuous Count Dependent 
Species 
Species of mosquitoes 
collected 
1 = Aedes albopictus 
2 = Aedes triseriatus 
Categorical None Independent 
Vegetation Vegetation type 
   1 = Yellow-poplar-white     
         oak-northern red oak 
   2 = Northern red oak 
   3 = Residential 
 
Categorical None Independent 
Precipitation Cumulative 
precipitation 





Table 13. Collected female mosquito totals and percentage yield by year, by CO2-baited CDC trapping. 
2004 2005 2006 
Species 
No. of 
mosquitoes % Species 
No. of 
mosquitoes % Species 
No. of 
mosquitoes % 
         
Ae. albopictus 857 49.0 Ae. albopictus 488 47.0 Ae. albopictus 865 59.0 
Ae. triseriatus 401 23.0 Ae. vexans 168 16.0 Ae. triseriatus 172 12.0 
Ae. vexans 148 8.4 Ae. triseriatus 132 13.0 Ae. vexans 151 10.0 
Aedes spp. 112 6.4 An. punctipennis 114 11.0 An. punctipennis 109 7.5 
Culex spp. 69 3.9 Aedes spp. 40 3.8 Culex spp. 77 5.3 
An. punctipennis 49 2.8 Cx. pipiens 36 3.4 Ae. japonicus 41 2.8 
Ae. japonicus 47 2.7 Culex spp. 28 2.7 Cx. pipiens 18 1.2 
Cx. pipiens 36 2.0 Ae. japonicus 27 2.6 Aedes spp. 17 1.2 
Ps. ferox 7 0.40 Or. signifera 4 0.38 Ur. sapphirina 2 0.14 
Ur. sapphirina 5 0.28 Ps. ferox 3 0.29 An. quadrimaculatus 2 0.14 
Cx. terriatans 5 0.28 Cx. restuans 2 0.19 Ae. trivitattus 2 0.14 
Anopheles spp. 3 0.17 Anopheles spp. 1 0.10 Anopheles spp. 1 0.07 
Mansonia spp. 3 0.17 Ae. trivitattus 1 0.10 Ps. ferox 1 0.07 
Cu. inoranta 3 0.17 Cx. tarsalis 1 0.10 Or. signifera 1 0.07 
Cx. restuans 3 0.17    Psorophora spp. 1 0.07 
An. perplexans 3 0.17       
Ae. atlanticus 3 0.17       
Cx. nigripalpus 2 0.11       
Cx. erraticus 2 0.11       
Ae. dupreei 2 0.11       
An. quadrimaculatus 1 0.06       
Ps. ciliata 1 0.06       
Ae. trivitattus 1 0.06       
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Table 13 Continued. Collected female mosquito totals and percentage yield by year, by CO2-baited CDC trapping. 
 
Ps. cyanesans 1 0.06       
Ae. sollicitans 1 0.06       
         




Table 14. Collected female mosquito totals and percentage yield, by a series of four separate human-
landing catches, 2004. 
Species No. of mosquitoes Percentage 
   
Ae. albopictus 363 69.0 
Ae. triseriatus 91 17.0 
Ae. trivitatus 30 5.7 
Ps. ferox 14 2.7 
An. punctipennis 6 1.1 
Ae. sticticus 6 1.1 
Aedes spp. 4 0.76 
Ae. atropalpus 3 0.57 
Anopheles spp. 2 0.38 
Ae. japonicus 1 0.19 
An. perplexans 1 0.19 
Ae. canadensis 1 0.19 
   
 Total mosquitoes 528  
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Table 15. The number and percentage of Aedes albopictus and Aedes triseriatus collected by time period, 
by a series of four separate human-landing catches, 2004. 
 





Total (Percentage) Total 
    
6:00 – 8:00 8 (34.8) 15 (65.2) 23 
8:00 – 10:00 19 (90.5) 2 (9.5) 21 
10:00 – 12:00 88 (76.5) 27 (23.5) 115 
12:00 – 14:00 29 (69) 13 (31) 42 
14:00 – 16:00 37 (90.2) 4  (9.8) 41 
16:00 – 18:00 75 (88.2) 10 (11.8) 85 
18:00 – 20:00 99 (87.6) 14 (12.4) 113 
20:00 – 22:00 8 (57.1) 6 (42.8) 14 
    
Total 363 (80) 91 (20) 454 
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Aedes albopictus collected exhibited two clear bimodal landing peaks between 10:00-
12:00 and 16:00-18:00, while Ae. triseriatus collected exhibited their largest peak 
between 10:00-12:00 and a smaller peak between 16:00-20:00 (Figure 12). 
The catch per hour for the total number of female mosquitoes collected in 2004, 
was 0.51 mosquitoes collected per hour for CO2-baited CDC trapping, and 8.8 
mosquitoes collected per hour by human-landing catches.  The catch per hour for both 
Ae. triseriatus and Ae. albopictus females collected in 2004, was 0.36 and 7.6 per hour by 
CO2-baited CDC trapping and human-landing catches respectively. 
Statistical analyses.  Species, vegetation, and cumulative precipitation were 
significantly (P < 0.05) associated with the number of mosquitoes collected by CO2-
baited CDC trapping (Table 16).  These variables could explain 12.12% of the variation 
in the total number of mosquitoes collected.  Species (Ae. albopictus), vegetation type 
(residential), and the cumulative precipitation for the four weeks prior to collection were 
all found to be significant predictors of total number of mosquitoes collected. 
Discussion 
Aedes albopictus was more abundant than Ae. triseriatus collected by CO2-baited 
CDC trapping and by human-landing catches at all sites, vegetation types, at probable 
and confirmed case sites, as well as sites with no reporting of LACV infections.  CO2-
baited CDC trapping in 1998 at two former cases sites of LACV infections demonstrated 
similar findings [35], and again in 2000 [16].  These results indicate that Ae. albopictus is 





Figure 12. The total number of Aedes albopictus and Aedes collected by series of human-landing catches* 
by collection time. 
 
*Mosquito collection totals came from the three separate human-landing catches where Aedes albopictus 




Table 16. Final model of the predictors of the number of the adult female host-seeking mosquitoes collected by CO2-baited CDC trapping in eastern Tennessee, 
2004 to 2006. 
Parameter Estimate p-value 
95% Confidence 
Interval 
    
Species (Aedes albopictus versus Aedes triseriatus) -3.216 0.000 -3.905, -2.527 
Vegetation (Yellow-poplar white-oak northern red-oak versus 
northern red-oak) 
0.668 0.149 -0.239, 1.576 
Vegetation (Residential versus northern red-oak) 3.181 0.000 2.117, 4.246 
Cumulative precipitation four weeks prior to collection 0.072 0.026 0.009, 0.136 




Aedes albopictus adults occurred in both space and time with serologically confirmed 
cases of LACV infections, as seen in previous studies results support previous findings 
that Ae. albopictus has become more abundant in peridomestic sites than Ae. triseriatus 
[16,35].  The presence of high numbers Ae. albopictus at case sites of LACV infections 
increase the likelihood that this species is playing a role in the transmission and /or 
maintenance of LACV in this region.  
It has been suggested that adult Ae. triseriatus may be under-sampled by light 
trapping and that the use of CO2-baited traps, battery powered aspiration, and/or human 
biting collections are better collection methods [122,151,177].  Previous work in the 
eastern Tennessee has demonstrated that more Ae. albopictus are collected than Ae. 
triseriatus using battery powered aspiration [38].  Our data suggest that Ae. triseriatus is 
not under-sampled by CO2-baited CDC trapping or by human-landing catches (Table 2, 
4) in peridomestic sites.  It is possible that the differences in the overall abundance of Ae. 
triseriatus and Ae. albopictus collected by these methods could be due to the different 
vegetation preferences of these species. 
In 2002, the first blinded cohort study investigating the clinical symptoms and 
environmental and entomological risk factors of LACV transmission in eastern 
Tennessee was undertaken [16].  Significant factors found to be associated with LACV 
transmission were the number of hours per day spent outdoors (5.9 for LACV infection 
cases vs. 4.0 for non-cases, p < 0.05), living in a residence with one or more tree holes 
within a 100 m radius from the dwelling (relative risk = 3.96, p < 0.05), and the burden of 
Ae. albopictus collected at sites (three times greater at cases than non-cases, p = 0.013).  
These data suggest that Ae. albopictus could be was playing a greater role in LACV 
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transmission in eastern Tennessee than elsewhere, e.g. Wisconsin.  No statistical 
difference was found in the burden of Ae. triseriatus around residences of LACV 
infection cases and non-cases.  Aedes albopictus was more abundant at all vegetation 
types.  This was most apparent at residential sites with three times as many Ae. albopictus 
collected by CO2-baited CDC trapping as Ae. triseriatus.  This is likely due to the ability 
of Ae. albopictus to colonize a wide range of environments including residential/urban 
[91], while Ae. triseriatus has traditionally been associated with forested areas [178].  
The vegetation preferences of these two species, may also explain why LACV isolations 
are much lower for Ae. albopictus than Ae. triseriatus [17].   
Aedes triseriatus is known to feed on a variety mammals including deer, squirrels, 
chipmunks and humans [86,114], while Ae. albopictus is considered a catholic feeder and 
is known to feed on a diverse range of mammalian, avian, and reptilian species 
[93,114,115].  The differences in feeding behaviors between these two species coupled 
with differences in vegetation/habitat preferences would make it more likely that a higher 
proportion of Ae. triseriatus would come in contact and to feed on the primary 
amplification hosts, the eastern chipmunk, Tamias striatus, the gray squirrel, Sciurus 
carolinensis, and the fox squirrel Sciurus niger [4,25,27,28].  Aedes triseriatus likelihood 
of involvement in horizontal transmission cycle, coupled with its higher midgut infection 
and dissemination rates of LACV through oral infection [88] make it the likely primary 
vector of LACV in this region.  It is probable that Ae. albopictus serves as an accessory 
vector, though its high abundance and aggressive biting in this region may overcome its 
shortcomings in its potential to acquire, develop, and transmit LACV. 
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Increased cumulative precipitation for the four weeks preceding collection was 
found to have a significant effect on the number of Ae. albopictus collected (Figure 9), 
and may allow Ae. albopictus immature stages to out compete Ae. triseriatus under 
certain conditions [179,180].  The presence of stable and/or increasing levels of water in 
containers and tree holes would also reduce the susceptibility of Ae. albopictus eggs to 
desiccation in drier environments [181,182] and would increase the fitness of Ae. 
albopictus to compete with Ae. triseriatus during the larval stage due to a reduction of 
environmental stress.  Residential areas in this region typically have high numbers of 
artificial containers [35], thus providing increased larval habitat for vector species.  
Stable and/or increasing water levels coupled with higher temperatures during the 
summer months would also allow for Ae. albopictus to develop at higher rates [183] and 
more rapidly than Ae. triseriatus [179]. Thus, the increased levels of precipitation during 
larval development would appear likely to have had a positive effect on the development 
of Ae. albopictus relative to Ae. triseriatus. 
In this study, Ae. triseriatus was most frequently captured between 10:00-12:00 
with a smaller peak between 16:00-20:00 (Figure 12).  These results differed from studies 
in Wisconsin, where [178] found the greatest biting activity was in the afternoon prior to 
18:00 and studies by [184] and [185] found that biting steadily increased from morning 
until mid-afternoon, though catches made by [185] in August, exhibited a similar bimodal 
peak in captures as our study reports.  These variations could be due the differences in 
collection methods, replications, climate, terrain, vector competition, and vegetation.  Our 
results are in agreement with Scholl et al. [184] in that the highest catches were made 
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during periods of the highest humidity (Figure 10).  It is likely that Ae. triseriatus bites 
throughout the day, with biting decreasing during the crepuscular period. 
Aedes albopictus was captured in two clear bimodal landing peaks; between 
10:00-12:00 and 16:00-18:00 (Figure 12).  These findings are in agreement with previous 
studies in east Asia that found two peaks of biting activity in both wooded and open areas 
[186,187].  Our results differed from these studies only in that the first peak of activity 
was the highest.  The presence of landing (probing/biting) Ae. albopictus at confirmed 
case sites of LACV infections further increases the chances that this species may be 
transmitting LACV to humans in this region.    
Our results demonstrate that the use of human-landing catches to collect these two 
vector species are more productive than by collections made by CO2-baited CDC 
trapping in this region.  The three human-landing catches where Ae. triseriatus and Ae. 
albopictus were captured accounted for 18 and 30 percent respectively of the total 
number of these two species collected during the entire 2004 trapping season.  An 
additional benefit to the use of human-landing catches where collections are made in 
tubes is that the tubes provide for better specimen preservation compared with collections 
made by CO2-baited CDC trapping. 
LACV infections became seasonally epidemic in eastern Tennessee coinciding 
with the establishment of Ae. albopictus, marking a significant increase in cases in 
eastern Tennessee from the previous 30 years.  This increase in cases could be a result of 
increased surveillance, diagnosis, and reporting for LACV infections following the 
outbreak in 1997, and/or could be a result of increased expansion of human settlements 
into virus foci, as well as due to the introduction and establishments of Ae. albopictus in 
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this region.  To date LACV has only been isolated from Ae. albopictus in eastern 
Tennessee.  Future studies are needed to address the presence of LACV within vector 
populations.  Aedes albopictus is currently the most abundant diurnal mosquito collected 
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The use of a variable-pressure scanning electron microscope (VPSEM) has many 
advantages over the conventional high vacuum SEM, which experiences several inherent 
weaknesses including: specimen preparation time, the inability to view specimens in their 
natural fully hydrated state, and the requirement of operating at high vacuum.  The use of 
a VPSEM overcomes the weaknesses of the SEM, minimizing shrinkage, mass loss, and 
eliminates charging in specimens, as well as the need for sample coatings. These 
advantages are particularly applicable for observing and imaging medically important 
insect specimens.  We explore the advantages of the VPSEM over the traditional SEM 
and the techniques for observing and the imaging of insect specimens using this 
microscope.  This note should be of interest to a broad audience of entomologists, in 
addition to researchers in the various fields of life science. 
Introduction 
The examination of the fine structures of insect specimens often requires the use 
of microscopy at the micrometer or smaller scale levels.  The viewing of ultrastructural 
detail is greatly aided by the use of a scanning electron microscope (SEM).  However the 
conventional SEM has several inherent weaknesses including specimen preparation time, 
the inability to view specimens in their natural fully hydrated state, and the requirement 
of operating at high vacuum.  We explore the advantages of the variable-pressure 
scanning electron microscope (VPSEM) over the traditional SEM and the techniques for 
The description and identification of the microscopic fine structures of medically 
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important insects are often not visible using light microscopy.  To overcome this 
limitation the scanning electron microscope (SEM) has been employed for the 
observation and imaging of such features [188].  The preparation of insect specimens for 
imaging using the SEM invariably requires the use of complex and time consuming 
techniques [189], and operation of the microscope under a high vacuum.  Here we 
examine the advantages of, and report techniques for, viewing and imaging specimens 
using the variable-pressure scanning electron microscope (VPSEM). 
Methodology 
In the VPSEM the specimen chamber is held at a finite gas pressure, typically in 
the range 0.01 to 3 Torr (1 to 400 Pa), rather than under the high vacuum (10
-6
 Torr or 10
-
4
 Pa) of the conventional SEM.  The pressure is controlled by the operator, and if 
desirable the contents of the specimen chamber can be changed from the default 
laboratory air to a pure gas such as helium, or to saturated water vapor.  The instrument 
can also be quickly restored to high vacuum operation by a simple adjustment of the gas 
injector system.  
The VPSEM has numerous advantages over the conventional SEM.  Specimen 
preparation time is greatly reduced as non-conductive specimens do not have to be coated 
with a thin metallic film and dried prior to imaging.  Such coatings are undesirable 
because they may obscure valuable surface detail, and the process of coating may change 
the inherent properties of the specimen being viewed.  Specimens, including wet or even 
fully hydrated examples, can also be viewed in their natural state using the VPSEM, 
which is not possible using the traditional SEM.  The use of air or water vapor in the 
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VPSEM negates the need to employ critical point drying to prepare samples [189], as 
biological specimens are not prone to collapse and distortion when their water content is 
maintained and stabilized.  The VPSEM operates at higher pressures than the standard 
high vacuum SEM, and this has the effect of scattering some of the electrons focused on 
to the specimen.  The result of this scattering is a small reduction in the signal level and a 
corresponding increase in noise, but resolutions of 2 to 4 nm  - fully comparable to those 
obtained in a normal SEM  - are still possible when using the VPSEM [190].  The 
magnitude of the scattering is controlled by using the lowest pressure that will maintain 
the stability and viability of the specimen, and reducing the working distance (i.e. the 
distance between the top of the specimen and the bottom of the objective lens of the 
SEM) to a few millimeters as compared to 10-15mm in a regular SEM. 
The following protocol for observing and imaging insect specimens was 
originally developed for mosquito eggs [191], though these same operational parameters 
could be applied to any insect specimens made up of soft tissue and containing water.  
The starting conditions for general observations using the VPSEM for insect specimens 
are as follows:   
 
1) The Beam Energy should be set between 20 to 30keV - lower energies may 
produce useful images but could result in more noise in the image.  
  
2) The beam current should be set to a value of 100pA or higher.  The scan rate 
is most conveniently chosen to be a visual scan rate (i.e. a frame rate of 
approximately one second) rather than television speed, which may not work 
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well.  If there is any subsequent evidence of damage or mass loss 
(“radiolysis”) the beam current should be reduced to the lowest value 
consistent with obtaining an acceptable image. 
 
3) The working distance should be set to be no greater than 8mm.  
 
4) On most VPSEMs the default imaging mode will use the backscatter detector 
although a dedicated Environmental SE detector (ESED) is provided on some 
instruments.  The backscatter detector will help to minimize any effects of 
beam induced charging on the specimen and will provide high contrast detail 
from regions of the sample differing in chemical composition. 
 
5) The gas environment within the chamber can use either laboratory air or, 
preferably, water vapor.  An initial gas pressure of 30Pa (0.25 Torr) is usually 
suitable, though pressure may need to be increased if there is evidence of 
charging.   
 
In the event that the sample needed to be kept fully hydrated as in the case of a 
specimen made up of soft tissue (eg. mosquito larva), then the samples temperature 
should be lowered to -10ºC or below and/or the pressure should be increased to 50-
100Pa. These changes will help keep the specimen on the boundary between the liquid 
and vapor states in the water phase diagram.  The lower the temperature the lower the 
chamber pressure required to keep the sample in a stable hydrated state.  The use of 
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saturated water vapor is generally preferable to normal laboratory air, because it helps 
minimize charging and distortions of the structure as a result of drying.  However 
providing a reliable source of pure, filtered, water vapor is not easy if extended operation 
is required. 
In the intention is to cool the specimen for observation the following procedure 
should be employed to load the sample into the VPSEM without allowing it to dry and 
shrink:  
 
1) Load the specimen on the SEM sample stage.  
 
2) Cool the specimen to the desired operating temperature e.g. -10C while leaving 
the sample exposed to the ambient environment. 
 
3) With the specimen maintained at its lowest temperature load the specimen into the 
VPSEM sample chamber and pump the sample to 100Pa or the desired operating 
pressure. 
 
4) Adjust the temperature and pressure to achieve the desired imaging condition. 
 
5) To remove the sample from the chamber without causing damage or shrinkage, 
bring the specimen chamber up to atmosphere pressure while holding the sample 
at the lowest temperature achieved, then turn off the cooling stage and allow the 
specimen to warm up in the ambient environment.  This sequence of steps will 
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prevent the specimen from being vacuum dried during pump down. 
Summary 
In summary, the use of a VPSEM provides many advantages when compared to a 
conventional high vacuum SEM. These include minimizing shrinkage and mass loss and 
eliminating charging and the need for sample coatings. These advantages are particularly 






Description of the Egg of Aedes japonicus japonicus (Diptera: Culicidae) using 
Variable Pressure Scanning Electron Microscopy 
 
This chapter is a lightly revised version of a paper by the name of “Description of the egg 
of Ochlerotatus japonicus japonicus (Diptera: Culicidae) using variable pressure 
scanning electron microscopy” published in the Journal of Medical Entomology in 2009 
by Andrew D. Haddow, John K. Moulton, Reid R. Gerhardt, Linda J. McCuiston, Carl. J. 
Jones: 
 
Haddow, A.D. J.K. Moulton, R.R. Gerhardt, L.J. McCuiston, and C.J. Jones. 2009. 
Description of the egg of Ochlerotatus japonicus japonicus (Diptera: Culicidae) using 
variable pressure scanning electron microscopy. Journal of Medical Entomology 46: 9-
14. 
 
*The genus Aedes has been substituted for Ochlerotatus in this Chapter for continuity 
within the dissertation. 
 
My contributions to this paper are 1) substantial contribution to conception and design, or 
acquisition of data, or analysis and interpretation of data; 2) drafting the article or 
revising it critically for important intellectual content; and 3) final approval of the 






The egg of Aedes japonicus japonicus (Theobald) is described with the aid of 
variable pressure scanning electron micrographs.  The egg is black, cigar shaped, and 
tapers ventrally.  The length is approximately 591 m and the width is approximately 172 
m. The outer chorionic cells are irregular in shape, either hexagonal or pentagonal, and 
decrease in size towards the anterior and posterior poles.  Ventral tubercles typically 
range from three to six and contact the chorionic reticulum.  Dorsal tubercles contain two 
large tubercles with small oval-shaped tubercles grouped around them.  A large thread-
shaped tubercle extends from this grouping either as a single tubercle or as a series of 
connected tubercles. The micropylar collar is low and discontinuous and is seldom 
complete.  This description will aid researchers in the identification of this invasive 
vector species. 
Introduction 
The previous range of Aedes (Finlaya) japonicus japonicus (Theobold) included 
Korea and Paleartic Japan [192]; it had also been collected in the former USSR [193].  
Since its introduction into the United States in 1999 [95,96] it has spread rapidly and 
poses a significant threat to the maintenance and transmission of arboviruses.  Aedes 
japonicus has been shown to be a competent laboratory vector of La Crosse virus [24], 
Eastern Equine encephalitis virus [194], St. Louis encephalitis [195], West Nile virus 
[196], and Japanese encephalitis virus [197].  Recently, this vector has been found at 
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several case sites of La Crosse encephalitis in eastern Tennessee (A.D. Haddow 
unpublished). 
Herein we describe the egg of Ae. japonicus with the aid of a variable pressure 
scanning electron microscope (VP-SEM).  This is the first use of a VP-SEM to describe a 
culicid egg. There are two partial descriptions of the egg of Ae. japonicus, both using 
traditional low-power SEMs.  The first shows the ventral (upper) chorionic surface and 
cells of a deformed egg [198], and the second shows the ventral (upper) chorionic cells 
[199].  We present this new data to assist field biologists in the identification of 
predominantly collected tree-hole species/container species, and to provide more detailed 
information on characters of Aedini eggs.  This brings the number of more complete 
descriptions and micrographs of the micropyle and associated structures of the subgenus 
Finlaya to three. 
Methodology 
Embryonated eggs were obtained from a laboratory colony at Rutgers University, 
New Jersey.  The colony was derived from field-collected individuals from Ocean and 
Somerset Counties, NJ, collected from 2000 to 2001.  Blood-fed mosquitoes were 
provided moist seed germination paper upon which to oviposit.  Eggs originated from 
five different females. Three eggs were randomly selected for analysis from each female. 
Microscopy was conducted using a Hitachi S-4300 SE/N VP-SEM (Hitachi High 
Technologies America, Inc).  VP-SEM is more versatile than traditional SEM due to a 
number of factors [200], most notably the ability to view specimens in their natural state, 
leading to a reduction in specimen preparation cost and time.  Measurements were made 
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using Image J (National Institutes of Health, USA).  Terminology follows that of 
Harbach and Knight [201], and Linely‟s [202] definition of “outer chorionic cell” and 
“cell field”.  Previous work used the mean length and width of the outer chorionic cells, 
but this procedure does not lend itself well to replication between researchers.  To 
enhance repeatability, the area of the cells was determined.  Descriptive statistical 
analyses were performed using STATA 10.0 (STATA Corp. College Station, TX). 
Results 
General Features.  The egg is black and cigar-shaped, tapers ventrally, and has a 
conspicuous micropylar collar (Figure 13)  The mean length (± SE) was 591 ± 7.6 µm; 
mean width was 172.3 ± 2.6 µm; the mean length/width ratio was 3.44 ± 0.06.  The outer 
chorionic cells are mainly hexagonal, though some are pentagonal.  Individual cell areas 
range from 177 to 355 µm
2
.  Dehiscence occurs transversely approximately ¼ from the 
anterior pole (Fig 14a, b). 
Ventral (Upper) Surface.  With the exception of the anterior and posterior poles 
the chorionic cells are primarily hexagonal and are variable in size (Figure 15a).  Within 
the cell fields tubercles range from three to six in number.  These tubercles are typically 
irregular in size and appear trapezoidal in shape, are flat topped or gently rounded, and 
are present throughout the cell field (Figure 15b).  Spoke-like bridges attach them on at 
least one side to cell floor and/or to the inner rim of the outer chorionic reticulum.  The 











Figure 14. (a) Transverse dehiscence, ventral (upper) surface, approximately ¼ from the anterior pole.  (b) 









Figure 15. (a) Ventral (upper) surface, typical outer chorionic cells, midway along the length of the egg.  
(b) Detail of the ventral chorionic cell structure showing five raised tubercles connected to inner rim of the 
outer chorionic reticulum by spoke-like bridges. Scale = 10 µm. 




Anterior Pole and Micropyle.  The outer chorionic cells diminish in size 
approaching the anterior pole (Figure 16a).  Tubercles decrease in number to two or three 
within the cell eventually fusing to each other and the reticulum walls (Figure 16b and c).  
The micropylar collar is low and discontinuous, with three to four narrow notches 
present, and is seldom complete (Figure 16d).  The micropylar collar width is highly 
variable, mean width at the narrowest point (± SE) was 3.77 ± 0.15 µm, mean width at 
the widest point (± SE) was 7.27 ± 0.27 µm; micropylar collar mean diameter (± SE) was 
31.2 ± 0.98 µm, the internal diameter (± SE) was 17.8 ± 0.47 µm; micropylar collar mean 
depth (± SE) was 3.18 ± 0.19 µm.  The micropylar disk is not clearly defined, is slightly 
domed, mean diameter of (± SE) 11.5 ± 0.38 µm. The micropyle itself has a mean 
diameter (± SE) of 1.69 ± 0.04 µm. 
Posterior Pole.  The outer chorionic cells diminish in size approaching the 
posterior pole (Figure 17a).  Tubercles may fuse to each other and the reticulum walls. 
Ventral-Dorsal Transition Areas and Dorsal (Lower) Surface. The transitional 
zone in Ae. japonicus is narrow, and occurs rapidly.  The dorsal (lower) surface outer 
chorionic cells become extremely irregular in shape.  Each cell contains two large 
tubercles with small oval shaped tubercles grouped around them; a large thread shaped 
tubercle extends from this grouping either as a single tubercle or as a series of connected 
tubercles (Fig 17b).  
Discussion 
Partial descriptions of Finlaya species eggs exist for Aedes togoi (Theobald), Ae. 





Figure 16. (a) Anterior pole, ventral surface.  (b) Outer chorionic cells, ventral surface, approaching the 
anterior pole.  (c) Anterior pole, ventral surface, outer chorionic cell detail.  (d) Top view, anterior pole and 







Figure 17. (a) Posterior pole, ventral (upper) surface.  (b) Detail of the outer chorionic cells, dorsal (lower) 




japonicus [198,203].  Two more complete descriptions exist for the eggs of Ae. 
alboannulatus (Macquart) and Ae. rubrithorax (Macquart) [204].  The characteristics 
listed in Table 17 form a basis of dimensions that could be useful for the separation of 
these species.  When compared to the descriptions of Ae. alboannulatus and Ae. 
rubrithorax [204] the Ae. japonicus specimens examined did not exhibit the mid-ventral 
strip of cells along the dorsal-ventral transition zone.  Of the seven Finlaya species 
forwhich partial and/or complete descriptions exist there are noticeable differences in the 
fine structure of the eggs [198,203,204].  Further work within this subgenus is needed to 
determine further differentiating characteristics. 
Aedes japonicus has been shown to be a competent laboratory vector of La Crosse 
virus [24], though its role in the natural maintenance and transmission of the virus has yet 
to be determined.  La Crosse virus was first isolated from the brain of a deceased 
pediatric patient who died of the virus in 1960 [1].  Since that time confirmed cases of 
LAC encephalitis have been reported to the Centers for Disease Control in 29 of the 
lower 48 states [9].  The primary vector in the upper Midwestern United States is Aedes 
triseriatus (Say) [2,20,94].  La Crosse virus has been isolated from Aedes albopictus 
(Skuse) in eastern Tennessee, and evidence suggests that this species may be involved in 
the maintenance and transmission of the virus in the region [16,17].  Aedes japonicus was 
collected in eastern Tennessee in 2003, and has since become established [99].  All three 
species‟ eggs have been collected together in tree-holes, ovitrap cups, and EPS float traps 
within their range, and therefore differentiating characteristics would prove useful in 
identifying these species (A.D. Haddow unpublished) (Table 18). The eggs of Ae. 




Table 17. Dimensions of the described eggs of Aedes (Finlaya) species. 
 Length ( m) Width ( m) Length/Width ( m) 
Species Mean  SE Range Mean  SE Range Mean  SE Range 
Ae. alboannulatus
a
 700.5  5.9 669.6 – 762.0 187.8  1.9 177.2 – 203.8 3.74  0.05 3.46 – 4.05 
Ae. albolateralis
b
 495  2 470 – 510  151  3 120 – 170  NA 
Ae. formosensis
b
 611  4 550 – 650  167  3 120 – 180  NA 
Ae. melanopterus
b
 572  3 550 – 590  169  5 130 – 200  NA 
Ae. rubrithorax
a
 682.3  6.1 632.9 – 727.8  179.6  1.9 165.8 – 192.4 3.81  0.06 3.49 – 4.37  
Ae. togoi
b







Table 18. Differentiating characteristics useful for identifying the tree-hole/container inhabiting mosquitoes involved in the transmission and/or 
maintenance of La Crosse virus in the United States. 





Total length range ( m) 545.3 – 636.7 NA 558.8 – 629.4 
Mean length  SE ( m) 591.0  7.6 680.8  9.6 609.8  5.9 
Total width range ( m) 161.7 – 186.7 NA 170.6 – 211.8 
Mean width  SE ( m) 172.3  2.6 201.6  2.0 192.9  2.4 
Total L/W ratio range ( m) 3.13 – 3.85 NA 1.97 – 3.42 
Mean L/W ratio  SE ( m) 3.44  0.06 3.15  0.05 3.28  0.04 
Micropylar collar range ( m) 25 – 38  36.0 (range not given) 45 – 50 
Width of micropylar disk 
range ( m) 
Not clearly defined, slightly 
domed, 
9.04 – 15.3 
Raised, 
18.0 
Not clearly defined, domed, 
18 - 21 
Micropylar orifice ( m) 1.7  0.04 (1.36 – 1.93) 2.0 3.3 
Outer chorionic cell shape Primarily hexagonal, some 
pentagonal 











albopictus is noticeably different.  With regard to size, Ae. triseriatus is the largest of the 
three species and likely could be differentiated from Ae. japonicus by length.  In terms of 
fine structure the eggs of Aedes albopictus, Ae. triseriatus and Ae. japonicus differ 
considerably and can be distinguished when examined under a stereomicroscope.  The 
egg of Ae. albopictus is shiny black in color, cigar shaped, tapering anteriorly and 
posteriorly, chorionic cells are regular in shape and contain one large rounded tubercle 
with small tubercles present on the inner walls of the outer chorionic reticulum [202].  
The egg of Ae. triseriatus is dull black in color, cigar shaped, the chorionic cells are 
irregular in shape, and one large tubercle is usually present touching the outer chorionic 
reticulum [205].  The egg of Ae japonicus, is matte black, cigar shaped, tapering 
ventrally, the chorionic cells are irregular in shape; tubercles usually range from three to 












This project set out to determine the current spatial and temporal patterns of 
disease risk for LACV at the national level, and then within Tennessee and West 
Virginia, and to determine the current vector ecosystem dynamics in eastern Tennessee. 
The results of studies have led to the creation of a national risk map, in addition to risk 
maps for West Virginia and eastern Tennessee, provided a national epidemiological 
picture of LACV infections, led to a further differentiation of the clinical presentation of 
LACV infections, provided additional information on the seasonal abundance, habitat 
preferences, and host-seeking behaviors of vector species in eastern Tennessee, provided 
further biological knowledge of vector species, and further incriminated Ae. albopictus as 
an accessory vector of LACV in eastern Tennessee.  These findings will allow focused 
national serological studies, form the basis for the development of predictive models of 
virus transmission, provide a methodology for the use spatial analyses at a national level 
for other infectious diseases, give specific recommendations for the reporting of arboviral 
disease cases, and will guide interventions by public health officials. 
Chapter III 
The findings of a higher incidence risk and case-fatality rate indicate a much 
higher burden of disease than previously reported, and demonstrate that LACV infections 
are much more common than previously reported. We have demonstrated the usefulness 
of spatial statistical techniques to detect hot-spots of infections at a national level, thus 
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allowing for targeted interventions by public health officials while raising awareness 
among health care providers of geographic areas at the highest risk of disease. 
This study provides the first true risk map of LACV for the United States, and 
presents insights into the clinical picture of LACV infections.  The results will allow 
focused national serological studies, form the basis for the development of predictive 
models of virus transmission, provide a methodology for the use spatial analyses at a 
national level for other infectious diseases, and demonstrate the need for the reporting of 
arboviral and other disease cases at smaller geographic scales.  
Chapter IV 
Focal arboviral infections affecting a sub-set of the overall population present an 
often over-looked set of challenges in the assessment and reporting of risk and the 
detection of spatial patterns.  The objective was to assess the variation of risk when using 
different at-risk populations and geographic scales for the calculation of incidence risk 
and the detection of disease clusters.  We explored these variations using a pediatric 
arbovirus, LACV, as our model. 
The results of this work indicate the possibility of missing disease clusters 
resulting from performing incidence risk investigations of focal diseases using 
inappropriate at-risk populations and/or large geographic scales.  Public Health efforts to 
improve both disease surveillance and health planning would be better improved through 
the assessment of risk in well-defined at-risk populations using the right geographic scale 
for a specific analysis.  This ensures that public health efforts to control disease 




The results of this study demonstrates that south-central West Virginia remains a 
focus of LACV transmission and highlights the utility of using the combination of 
incidence risk and spatial statistics to detect areas of high virus transmission.  West 
Virginia continues to have the highest reported case-fatality rate in the United States.  
Clusters of high risk were detected in areas where previous work indicated a high 
presence of Ae. japonicus and Ae. triseriatus, and low numbers of Ae. albopictus.  The 
presence of wooded areas and artificial containers in virus foci remain a risk factor for 
acquiring LACV.  These findings will allow public health officials to target these areas 
for interventions.   
Chapter VI 
Aedes albopictus was found to be the most abundant mosquito collected at all 
sites and vegetation types, by both CO2-baited CDC trapping and human landing catches.  
It exhibited two clear peaks of “landing” activity, one in the early morning and one in the 
late afternoon or early evening.  Species (Ae. albopictus), vegetation (residential), and the 
previous cumulative precipitation for the four weeks prior to collection were significantly 
(P < 0.05) associated with the number of mosquitoes collected by CO2-baited CDC traps.  
This work further implicates Aedes albopictus as an accessory vector of LACV in eastern 
Tennessee. 
Chapter VII 
The use of a VPSEM has many advantages over the conventional high vacuum 
SEM, which experiences several inherent weaknesses.  The use of a VPSEM overcomes 
 
 149 
the weaknesses of the SEM.  These advantages are particularly applicable for observing 
and imaging medically important insect specimens.  This work explored the advantages 
of the VPSEM over the traditional SEM and the techniques for observing and the 
imaging of insect specimens using this microscope.  This work is relevant to a broad 
audience of entomologists, in addition to researchers in the various fields of life science. 
Chapter VIII 
Prior to this work, no complete description of the egg of Ae. japonicus existed in 
the literature, hampering efforts to identify and distinguish eggs collected during 
ovitrapping from other species.  This work will assist field biologists in the identification 
of the egg of Ae. japonicus and other predominantly collected tree-hole species/container 
species, provide more detailed information on characters of Aedini eggs, while bringing 
the number of more complete descriptions and micrographs of the micropyle and 
associated structures of the subgenus Finlaya to three. 
Future Research 
 These results of the studies in Chapters III, IV, and V infer the wide variation in 
risk that occurs due to the focal nature of the virus.  Future work is needed to develop 
predictive models for LACV that incorporate vector competence in different geographic 
regions, host data, climate data, vegetation data, and case data.  Ecological niche 
modeling of LACV virus in an endemic area e.g. West Virginia, could form the basis of a 
national model. 
 It is clear from the results of Chapters III, IV, and V that the vast majority of 
cases remain undiagnosed and/or underreported, and the results from previous work 
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elsewhere support this hypothesis, with estimates of asymptomatic infections to clinical 
infections in pediatric populations ranging from 2:1 to 1500:1 [13,36,124].  There is a 
current need for serosurveys in LACV endemic areas, to gauge the prevalence of the 
virus in these populations.  Such work could give clues to the virulence of strains 
circulating in various different geographical regions while allowing guided health 
intervention efforts to those areas of highest risk. 
 It is clear from the results in Chapters III, IV, and V as well as previous work 
elsewhere [2,29,45,46,118,131] that the vast majority of severe LACV infections occur 
children, but the question still remains why?  This could be due to a variety of factors 
including differences in the pediatric and host immune system, the dose of virus as 
children would receive a proportionally larger dose than adults by weight, and/or 
exposure.  These hypotheses need to be studied further, and may shed light on virus/host 
interactions in other systems. 
 There remain relatively few virus isolates obtained from vector species in the 
Appalachian region of the United States [9,17,36], and work is needed to confirm the 
current status of Ae. triseriatus, Ae. albopictus, and Ae. japonicus as vectors of LACV in 
this region.  Chapters III, IV, V, and VI and previous studies in West Virginia [18,19,33], 
indicate the possibility of Ae. albopictus serving as an accessory vector in eastern 
Tennessee and/or Ae. japonicus serving as and accessory vector in West Virginia, but the 





 Currently, state health departments report LACV infections at the county level, 
but the results of Chapter IV have demonstrated the sub-county level ie the census tract 
would provide a more accurate picture of disease risk, while reducing the chances of 
missing disease clusters using Global and Local Morans I statistics.  It would therefore be 
beneficial to for state health departments to begin reporting LACV cases to the CDC at 
the census tract level. 
 Traditionally, LACV infections have been reported as LAC encephalitis [5].  
Such reporting distorts the true picture clinical presentation of severe LACV infections.  
LACV infections present as meningioencephalitis, encephalitis, meningitis, or 
uncomplicated fever, Chapters III and V.  The accurate long-term reporting of the clinical 
presentation will allow for comparisons to be made between age, sex, and geographic 
region and may provide clues to the virulence of different LACV strains. 
 The significantly high risk clusters detected in Chapters III, IV, and V should be 
used by public health officials to guide intervention efforts in those areas of highest risk.  
Public heath officials should continue to educate the public on possible risk factors for 
acquiring LACV infections, such as age, time outdoors and the presence of disease foci, 
Chapters III, IV, V, and VI. 
 The examination of the fine structures of insect specimens requires the use of 
microscopy at the micrometer or smaller scale levels.  Traditionally, conventional SEM 
and critical point drying are used to facilitate the viewing of these specimens, but suffer 
from inherent weaknesses.  The use of VPSEM overcomes these weaknesses, and should 
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be used when possible to view specimens, allowing specimens to be viewed in their 
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